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The human gut is home to an enormous number of microbes that play an 
important role in host physiology, metabolism, nutrition and immune function. 
Deviations in initial human gut microbiota development have been associated 
with a number of immune-mediated diseases including inflammatory bowel 
diseases, atopy and allergies, as well as obesity, which are reaching epidemic 
proportions in the westernized world. However, gut microbiota dysbiosis has 
also been linked to health problems common in the developing world including 
malnutrition. The aim of this thesis was to unravel the impact of specific 
factors, including environment, geographical location, diet and mother’s 
microbiota, on the gut microbiota development in early infancy. 
Analysis of gut microbiota composition of six-month-old infants from 
Malawi and Finland, representing developing and westernized countries, 
revealed that the Malawians had a distinct Lactobacillus microbiota that was 
richer and more diverse compared to their Finnish counterparts. Interestingly, 
we detected L. rhamnosus GG, a widely used probiotic in Finland, in a third of 
the Finnish infants even though the infants or their mothers did not receive any 
probiotic products. For the detection, we used a L. rhamnosus GG strain-
specific detection system, whose specificity was confirmed in this thesis. In 
addition, we noted that lipid-based nutrient supplements do not have an impact 
on gut microbiota development in Malawian infants. These dietary supplements 
have been used in several clinical trials to promote growth of children from 
developing countries, but their impact on the gut microbiota has been 
previously unknown. In addition to environment and diet, a number of host 
factors may have an impact on the gut microbiota development. Here, we 
assessed how mother’s microbiota influences the gut microbiota development 
in early infancy by comparing samples of maternal feces, placenta, amniotic 
fluid, colostrum, meconium and infant feces from mother-infant pairs. Our 
results suggest that the microbial colonization may begin already during fetal 
life. After birth, colostrum seems to influence the gut microbiota development 
of the neonate by serving as a source of microbes and microbiota modulating 
factors, such as human milk oligosaccharides. We also noted that human milk 
oligosaccharides and microbiota of the colostrum are interrelated. 
Taken together, this thesis provides further knowledge on how different 
factors influence gut microbiota development in early life. Modification of gut 
microbiota composition during its development may be a viable strategy to 






Ihmisen suolistossa asuu valtava määrä mikrobeja, jotka vaikuttavat 
merkittävästi ihmisen fysiologiaan, metaboliaan, ravitsemukseen ja 
immunijärjestelmän toimintaan. Suoliston mikrobiston kehityksen häiriöiden 
on todettu olevan yhteydessä lukuisiin immuunivälitteisiin sairauksiin, kuten 
tulehduksellisiin suolistosairauksiin, atopiaan, allergioihin ja liikalihavuuteen. 
Nämä sairaudet ovat yleistyneet etenkin länsimaisissa hyvinvointivaltioissa 
viime vuosikymmeninä. Lisäksi viime aikoina on havaittu, että suoliston 
mikrobiston häiriöt ovat yhteydessä kehittyvissä maissa yleisiin sairauksiin 
kuten aliravitsemukseen. Tämän väitöskirjatyön tavoitteena oli tutkia eri 
tekijöiden kuten ympäristön, maantieteellisen sijainnin, ruokavalion ja äidin 
mikrobiston vaikutusta suoliston mikrobiston kehitykseen varhaislapsuudessa. 
Malawilaisten ja suomalaisten kuuden kuukauden ikäisten lasten 
suolistomikrobiston analyysi osoitti, että malawilaisilla oli rikkaampi ja 
monipuolisempi Lactobacillus –mikrobisto, jonka koostumus oli selkeästi 
erilainen kuin suomalaisilla. Tutkimuksessa havaittiin yllättäen, että 
kolmasosalla suomalaisista lapsista oli L. rhamnosus GG probioottia 
suolistossa, vaikka lapset tai äidit eivät olleet nauttineet probioottituotteita. 
Havainto tehtiin käyttäen L. rhamnosus GG laji-spesifistä PCR-pohjaista 
menetelmää, jonka tarkkuus arvioitiin ja todettiin hyväksi tässä 
väitöskirjatyössä. Lisäksi osoitettiin, että rasvapohjaiset ravintolisät eivät 
vaikuta malawilaisten lasten suolistomikrobiston kehitykseen. Rasvapohjaisilla 
ravintolisillä on pyritty ehkäisemään lasten aliravitsemusta kehitysmaissa, 
mutta niiden vaikutusta suoliston mikrobistoon ei ole aikaisemmin tunnettu. 
Ympäristön ja ruokavalion lisäksi monet isännästä riippuvat tekijät voivat 
vaikuttaa suoliston mikrobiston kehitykseen. Tässä työssä selvitettiin äidin 
mikrobisto vaikutusta lapsen mikrobiston kehitykseen varhaislapsuudessa 
vertailemalla mikrobistonäytteitä äidin ulosteesta, istukasta, lapsivedestä, 
äidinmaidosta, mekoniumista, sekä lapsen ulosteesta. Tulokset osoittivat, 
suoliston kolonisaatio alkaa mahdollisesti jo ennen syntymää kohdussa. Tämän 
jälkeen lapsen mikrobiston kehitykseen vaikuttavat rintamaidon sisältämät 
mikrobit ja mikrobistoa muokkaavat tekijät, kuten äidinmaidon oligosakkaridit. 
Työssä havaittiin myös, että äidinmaidon oligosakkaridit ja mikrobisto ovat 
yhteyksissä toisiinsa. 
Tämä väitöskirjatyö tuotti uutta tietoa siitä kuinka eri tekijät vaikuttavat 
suolistomikrobiston kehitykseen. Suoliston mikrobiston muokkaaminen 
kehityksen eri vaiheissa voi olla yksi toimiva vaihtoehto tulehduksellisten ei-
tarttuvien sairauksien ehkäisemiseen ja parantamiseen tulevaisuudessa.
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GEE, generalized estimating equations 
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16S rRNA, Bacterial ribosomal 16S RNA molecule 
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The colonization of the human gastrointestinal tract is a gradual process that is 
affected by host genotype, mother’s microbiota, mode of delivery, gestational 
age, early feeding practices and the environment. Early microbial contact is 
essential for healthy intestinal and immunological development during infancy 
and thus can have long-term effects on the risk of gastrointestinal, immune-
mediated and metabolic disease in later life. It has been hypothesized that a 
lack of microbial contact during infancy is one of the reasons for the increase in 
allergic and other chronic inflammatory diseases such as obesity and related 
disorders in the modern societies (Strachan, 1989; Isolauri et al., 2009). In 
addition, deviations in gut microbiota composition have been also linked to 
diseases common in the developing world such as bacterial or viral diarrhea, 
and, more recently, malnutrition (Gordon et al., 2012; Smith et al., 2013).  
During first years of life, the human microbiota is a dynamic ecosystem 
dominated by lactobacilli and bifidobacteria (Bäckhed et al., 2015; Koenig et 
al., 2011). Recent reports suggest that fetus may be exposed to microbes or 
microbial parts already in utero: microbial DNA in amniotic fluid and placenta 
has been noted by several studies (Satokari et al., 2009; Rautava et al., 2012b). 
However, current knowledge on the role of intrauterine microbes in human gut 
colonization is scarce. Following birth, breastfeeding is a major source of 
viable microbes and microbiota modulating factors, including human milk 
oligosaccharides, to the newborn infant (Jost et al., 2015). Moreover, the gut 
microbiota may be affected by hygiene and sanitation and other environmental 
factors such as the presence of animals.  
In the present study, we aimed to characterize the transfer of microbiota 
from mother to infant more thoroughly than before and to reveal other factors, 
such as geographic location and diet, that influence the gut microbiota 
development in early infancy. Comprehensive understanding of the 
mechanistic basis of microbiota development and the factors that have an 
impact on it may reveal new therapeutic approaches that could be used to 
modulate the gut microbiota to treat or prevent non-communicable diseases 
including allergic, autoimmune and inflammatory disorders. 
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2 REVIEW OF THE LITERATURE 
2.1 Human gut microbiota composition 
An average human body harbors approximately the same amount of microbial 
cells as eukaryotic cells and their genes outnumber the human genes by more 
than 100-fold (Sender et al., 2016; Human Microbiome Project Consortium, 
2012). The human microbiota is composed of all three domains of life: Bacteria, 
which predominate, Archaea, and Eukarya, and viruses.  
The majority of the human microbiota resides in the gastrointestinal tract. 
Nevertheless, relatively few bacterial phyla reside in the human gut compared 
to communities in other body sites. The adult gut microbiota consists 
predominantly of two bacterial phyla, Firmicutes and Bacteroidetes, which are 
followed by Actinobacteria, Fusobacteria, Proteobacteria and Verrucomicrobia 
(Eckburg et al., 2005). It has been estimated that the gut microbiota consists of 
an average of 500-1000 different microbial species with great variation 
between individuals (Jalanka-Tuovinen et al., 2011). During the first 2-3 years 
of life the human gut microbiota is in a dynamic state progressively changing 
and becoming more diverse after which it stabilizes, and remains rather stable 
during adulthood. At later stages of life the microbiota composition becomes 
less diverse and again more dynamic (Ottman et al., 2012). 
The concentration and diversity of microbiota increases when moving from 
the esophagus distally to the rectum. In the esophagus and stomach, the number 
of bacteria can be around 10 per gram whereas in the colon and distal gut the 
bacterial cell count can reach 1012 per gram of contents (O’Hara and Shanahan, 
2006). Different bacterial groups are known to colonize different parts and sites 
in the gastrointestinal (Figure 1). Stomach and small intestine are more harsh 
environments for the microbes compared to colon because of low pH and 
presence of bile salts, respectively. In addition to being bile tolerant the small 
intestinal microbiota reflects a community that can quickly respond to varying 
carbohydrate availability (Zoetendal et al., 2012).  
Based on recent studies, the small intestine is mainly colonized by Bacilli 
(Streptococcus sp.), Clostridium cluster XIVa and coliforms (Zoetendal et al., 
2012). The microbiota in colon is more stable, but more diverse than in the 
small intestine. The colon is mainly populated by strict anaerobic 
microorganisms which form a complex and dynamic ecosystem (Eckburg et al., 
2005).  
In addition to differences in microbiota between different longitudinal parts 
of gastrointestinal tract, there is also variation in microbiota at latitudinal level 
of the intestine. The intestinal epithelium is separated from the lumen by a 
thick layer of mucus, which serves as a barrier that protects the underlying 
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epithelial cells from pathogens as well as physical and chemical damage. The 
luminal and mucosal parts of the intestinal lining have been shown to differ in 
microbiota composition (Zoetendal et al., 2002). The luminal microbiota tends 
to be dynamic and it is mainly affected by diet, while the mucosal microbiota is 
more stable. The luminal part has two specific layers: digesta and inter-fold 
regions. Species of the families Bacteroidaceae, Prevotellaceae and 
Rikenellaceae populate the digesta while the inter-fold regions are colonized by 
species of Lachnospiraceae and Ruminococcaceae families (Donaldson et al., 
2016). Also the mucus layer can be also divided into two distinct intersections: 
the loose outer layer and the dense inner layer close to the epithelium. The 
loose outer layer of mucus is populated by mucin-degrading bacteria, such as 
Bacteroides acidifaciens, Bacteroides fragilis and Akkermansia muciniphila 
(Salyers et al., 1988; Derrien et al., 2004; Donaldson et al., 2016). The inner 
layer of mucus has been earlier described as devoid of bacteria (Johansson et 
al., 2008), but recent studies suggest that low levels of Bacteroides fragilis and 
Acinetobacter spp. may reside closer to the epithelium (Donaldson et al., 2016; 
Pédron et al., 2012).  
 
 
Figure 1. Variations in microbial numbers and composition across the human 
gastrointestinal tract 
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2.2 General functions of the human gut microbiota 
The gut microbiota could be considered as an organ placed within an organ 
since it plays an essential role in the metabolic, nutritional, physiological and 
immunological processes of the human body (O’Hara and Shanahan, 2006). 
The microbiota extracts energy from otherwise indigestible dietary 
polysaccharides such as resistant starch and different dietary fibers. This leads 
to the production of important nutrients such as short-chain fatty acids, 
vitamins and amino acids, many of which humans are unable to produce 
themselves (LeBlanc et al., 2013; Neis et al., 2015; Cummings, 1984). The 
microbiota also participates in the defense against pathogens by producing 
antimicrobial compounds and by providing so called colonization resistance, 
which means that the microbiota protects itself directly or indirectly against 
incursion by new and often pathogenic microorganisms (Buffie and Pamer, 
2013). Commensal microbes also have an impact on the normal development 
and maintenance of the gastrointestinal sensorimotor functions (Barbara et al., 
2005). Moreover, the gut microbiota has an important role in the normal 
development of the mucosal immune system, the induction of IgA production 
and epithelial barrier tightening (Ulluwishewa et al., 2011; Macpherson et al., 
2008; Lepage et al., 2013; Sutherland et al., 2016). 
2.3 Gut microbiota in health and disease - the extended 
hygiene-hypothesis 
The so-called hygiene hypothesis suggested that a lack of exposure to 
infectious agents such as microorganisms and parasites in childhood may 
suppress immune system development and lead to increased prevalence of 
allergies and atopic disease (Strachan, 1989). Since the days of Strachan, we 
have learned that the gut microbiota is central to this phenomenon. The human 
gut microbiota and its host have co-evolved, but due to changes in our lifestyle 
and environment, we are losing key players of the microbiota as well as 
reducing overall diversity (Blaser and Falkow, 2009; Ley et al., 2008). It also 
seems that some microbes traditionally considered as pathogens, such as H. 
pylori, may in fact be protective against allergic disease for instance, and thus 
their systematic eradication may have surprising consequences (Seiskari et al., 
2007; Ozerlat, 2011). Loss of specific microbial species that have a role in 
human health and decrease in overall diversity of the microbiota may carry 
over from generation to generation, possibly in an irreversible manner 
(Sonnenburg et al., 2016). 
Dysbiosis in the gut microbiota appears to be associated with more diseases 
than before, but the mechanisms are not well understood. In addition to allergic 
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disease, relatively strong evidence supports the role of gut microbiota dysbiosis 
in inflammatory bowel diseases, celiac disease, diabetes and obesity (Vos and 
Vos, 2012). Interestingly, associations between central nervous system diseases 
such as autism and Alzheimer’s disease have also been proposed (Toh and 
Allen-Vercoe, 2015; Bhattacharjee and Lukiw, 2013). However, it is important 
to recognize that the so-called gut-brain axis is bidirectional and until now only 
associations have been reported (Collins and Bercik, 2009). Nevertheless, 
studies conducted on laboratory animals suggest that gut microbes may actually 
alter behaviour via influencing the vagus nerve (Bravo et al., 2011). 
Although it is clear that microbiota plays an important role in human health 
and disease, there is still no consensus on what is a “healthy” gut microbiota 
composition or if it even exists. More detailed studies are needed and also work 
reporting compositional differences of genetic origin or geographical location. 
2.4 Host-microbe interactions 
2.4.1 Lessons from germ-free animals 
The gastrointestinal tract is the primary site of interaction between the host 
immune system and microorganisms, both symbiotic and pathogenic. The gut 
microbiota plays a key role in the maturation of the immune system and the 
structure and function of the gastrointestinal tract. Our understanding of early 
host-microbe interactions is mainly based on studies utilizing germ-free or 
gnotobiotic animals. Germ-free animals are more susceptible to infection by 
various pathogens because they have various developmental defects of the 
immune system. For instance, they show deficits in the development of gut-
associated lymphoid tissues (GALT), numerous defects in the antibody 
production as well as fewer and smaller Peyer’s patches and mesenteric lymph 
nodes (Round and Mazmanian, 2009). However, they can provide mechanistic 
answers to microbiota-host interactions. Nevertheless, one has to be careful 
when extrapolating results from studies conducted with mice to humans. 
One famous study utilizing germ-free animals to demonstrate the role of gut 
microbiota in immune system development was conducted by Sudo et al. 
(1997). In this pioneering study the authors showed that monocolonizing a 
germ-free mouse with a B. infantis strain during the neonatal period could 
induce immune tolerance in an animal that normally lacks one. In the same 
study the authors demonstrated that colonization at an older age did not lead to 
immune tolerance. This indicates that an early microbial exposure is needed for 
the normal development of immune tolerance. In a similar vein, the impact of 
the gut microbiota on the function and structure of gastrointestinal tract has 
been demonstrated by monocolonizing germ-free mice with Bacteroides 
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thetaiotaomicron. The monocolonization had an impact on the expression of 
various host genes that influence nutrient uptake, metabolism, angiogenesis, 
mucosal barrier function and the development of the enteric nervous system 
(Xu and Gordon, 2003). 
In addition to monocolonization of germ-free mice, whole microbiotas have 
been transplanted to see the impact of gut microbiota on host health. For 
instance, the causal relationship between gut microbiota dysbiosis and obesity 
was confirmed when gut microbiota of obese lepob mice and lean wild-type 
mice was transplanted to germ-free mice (Turnbaugh et al., 2006). This study 
demonstrated that there was a greater increase in body fat for mice colonized 
with a gut microbiota associated with obesity. Later, similar findings were 
reported when microbiota was transplanted from obese humans and their lean 
twins to germ-free mice (Ridaura et al., 2013). 
2.4.2 Mechanisms of immunomodulation by gut microbiota 
Various pattern recognition receptors (PRRs), such as Toll-like receptors and 
nucleotide-binding oligomerization domain- (NOD-) like receptors (NLRs), are 
key mediators in the communication between the host and the gut microbiota 
(Figure 2). The TLRs are mostly present on the membrane of immune and 
epithelial cells (Kawai and Akira, 2006) while NODs are present in the 
cytoplasm of enteric cells (Lavelle et al., 2009). These receptors are 
evolutionary conserved molecules that promote immune responses by 
recognizing conserved molecular motives such as microbe-associated 
molecular patterns (MAMP) and pathogenic-associated molecular patterns 
(PAMP) (Kubinak and Round, 2012). The TLR family consists of eleven 
different transmembrane proteins, which are specialized in recognizing 
different microbial molecules. These molecules include lipopolysaccharides on 
the cell membrane of Gram-negative bacteria (TLR4), peptidogylcan (TLR2), 
bacterial flagellin (TLR5), lipoteichoic acid of Gram-positive bacteria (TLR1 
and TLR6) and unmethylated CpG-motifs (TLR9) and muramyl dipeptide 
(NOD2). 
Specific bacteria have been shown to shape the intestinal immune response 
via specific TLRs. For instance, TLR2 has been shown to be activated by a 
unique surface polysaccharide (polysaccharide A, PSA) of Bacteroides fragilis 
(Figure 2) (Round et al., 2011). Before this mechanism was known, it was 
noticed that PSA can correct the systemic T cell deficiencies in germ-free mice 
(Mazmanian et al., 2005). Later, it was shown that the PSA expressed by B. 
fragilis regulates the development of Foxp3+ regulatory T (Treg) cells while 
suppressing the TH17 responses (Round and Mazmanian, 2010; Round et al., 
2011). The Treg and TH17 possess opposing actions and the imbalance between 
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these two has been suggested to be a contributing factor in various immune-
mediated diseases (Eisenstein and Williams, 2009). 
The gut microbiota derives various compounds from food that the host 
consumes. For instance, microbes produce short-chain fatty acids, such as 
acetate, propionate and butyrate, from non-digestible dietary carbohydrates and 
thus their levels are highly dependent on the diet of the host as well as the 
community structure of the microbiota (David et al., 2014; Flint et al., 2015; 
Scott et al., 2013). After their production, SCFA are absorbed and used for 
different biosynthetic purposes by the host. For instance, epithelial cells in the 
colon obtain most of their energy from these bacterial metabolites (Macfarlane 
and Macfarlane, 2012). SCFAs, butyrate in particular, also play an important 
role in the maintenance of gut barrier function: both by increasing mucin 
production which may result in changes on bacterial adhesion (Jung et al., 2015) 
and improving tight-junction integrity (Peng et al., 2009). Moreover, butyrate 
is known to regulate the proliferation and activation of regulatory T cells in the 
colon (Figure 2) (Furusawa et al., 2013). Interestingly, SCFAs may also have a 
critical role in appetite regulation and energy homeostasis (Frost et al., 2014; 
Lin et al., 2012). 
 
Figure 2. Immunomodulation by gut microbes. PSA, polysaccharide A; SCFA, 
short chain fatty acid; SFB, segmented filamentous bacteria 
2.5 Development of gut microbiota 
The microbiota of a healthy, breastfed, vaginally delivered, full-term infant 
who remains healthy for a longer follow-up time is considered as the gold 
standard for microbiota development (Collado et al., 2015). Microbiota during 
infancy has been described as less diverse and more dynamic than an adult’s 
microbiota and it is dominated by bifidobacteria and lactobacilli (Yatsunenko 
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et al., 2012; Ottman et al., 2012). As the infant ages, the diversity of the 
microbiota increases with the emergence and dominance of the phyla 
Firmicutes and Bacteroidetes (Rodríguez et al., 2015; Ottman et al., 2012). 
Since the microbes living in human gut are not found in other environments, 
it seems logical that the human infant inherits a majority of its microbiota from 
its mother (Rautava et al., 2012b; Ley et al., 2006). It has been proposed that 
the mother’s gut microbiota changes towards a composition that is beneficial 
for both the mother and the infant (Koren et al., 2012). During pregnancy, the 
gut microbiota of a pregnant mother has been shown to change particularly 
during the thid trimester and it is characterized by a decreased diversity with a 
decrease in the abundance of Faecalibacterium spp. and an increase in 
Proteobacteria, Streptococcus spp. and Actinobacteria (Koren et al., 2012). 
Apart from mother’s microbiota, type of feeding, environment and the use of 
antibiotics, probiotics and prebiotics may influence the microbiota 
development of the infant. 
2.5.1 Is there microbial contact in utero? 
Since the studies conducted by Tissier (Tissier, 1900) in early 20th century 
concerning the acquisition of gut microbiota during infancy, the idea that the 
fetus is sterile and that microbial colonization starts after birth was widely 
accepted. When thinking from an evolutionary point of view, this dogma of the 
microbiologically and immunologically naïve fetal life seems bizarre, since 
humans among other mammals have evolved in a world already inhabited by a 
colossal variety of different microorganisms (Rautava et al., 2012b). Currently, 
there is increasing evidence, although still lacking, that the fetus may be 
exposed to microbes or microbial parts already in utero. Thus, it has been 
suggested, that the intrauterine environment provides the embryo and fetus a 
controlled environment in which there is limited and selective exposure to 
microbes during the vulnerable periods of early development (Rautava et al., 
2012b). 
Microorganisms in the amniotic fluid and placenta have been mainly 
associated with intrauterine infections and preterm deliveries (Goldenberg et al., 
2008). Anyhow, bacterial DNA has been reported also in placenta and amniotic 
fluid in normal conditions (Satokari et al., 2009; Rautava et al., 2012a; 
Aagaard et al., 2014). In addition, intact bacteria have been detected in the 
basal plate of placenta in both term and preterm gestations (Stout et al., 2013) 
and bacterial cells have been obtained by culturing from amniotic fluid 
(DiGiulio et al., 2008). 
In addition to amniotic fluid and placenta, meconium, which was also 
thought to be sterile in the past, seems to have a complex, albeit low abundance, 
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microbiota (Dominguez-Bello et al., 2010; Gosalbes et al., 2013; Mshvildadze 
et al., 2010). In fact, the meconium microbiota has been reported to reflect 
maternal health and also to be associated with the development of disease in 
offspring (Gosalbes et al., 2013). However, often it is not clear how long after 
membrane rupture or birth the meconium has been passed, and thus it cannot be 
ruled out that the bacteria in the meconium origin from elsewhere than the 
intrauterine environment. Moreover, it must be kept in mind that DNA-based 
methods are prone to contamination and possible background DNA when 
assessing microbiota in low-biomass sites such as placenta or meconium (Salter 
et al., 2014). Therefore proper negative controls should be included and the 
results interpreted with caution since they may provide a distorted image of the 
real bacterial population in the low-biomass samples. 
If assumed that the intrauterine environment is not sterile, the route that 
bacteria may use to enter the amniotic cavity remains to be elucidated. It has 
been suggested that microbes might ascend from the vagina and the cervix, 
haematogenously disseminate through the placenta, or spread through the 
fallopian tubes from abdominal cavity (Goldenberg et al., 2008). It seems that 
bacterial DNA is frequently detected in the amniotic fluid already during the 
second trimester and is not always associated with adverse outcome or 
inflammation (Markenson et al., 2003). It is also known that non-pregnant 
women have a microbiota in the uterus with a distinct composition compared to 
the vaginal microbiota (Andrews et al., 2005; Verstraelen et al., 2016). 
Interestingly, bacterial efflux from mother to fetus has been demonstrated in 
mice. Jimenez and coworkers inoculated a genetically labeled Enterococcus 
faecium strain orally to pregnant mice and later isolated it from the amniotic 
fluid of the inoculated animals (Jimenez et al., 2005, 2008). Also, specific 
bacteria have been isolated from the cord blood from healthy neonates born by 
cesarean section (Jimenez et al., 2005) suggesting the possible mother-to-infant 
efflux of commensal microbes via blood in humans also. 
One of the main arguments against the in utero colonization hypothesis is 
that we are able to derive “germ-free” animals by hysterectomy (Arvidsson et 
al., 2011) or embryo transfer (Inzunza et al., 2005), and thus in utero 
colonization would not happen. However, this does not exclude the possibility 
that, during fetal life, humans or other animals may be exposed to microbial 
parts or non-proliferating microbes, which may have an impact on the 
development of the immune system for instance. As indicated by a study by 
Rautava and coworkers (2012a), the microbe-associated molecular patterns 
(MAMPs), such as bacterial DNA, can induce immuno-stimulatory effects via 
the stimulation of TLRs without the need for microbial cells to enter the 
amniotic cavity (Rautava et al., 2012a). Data also suggests that fetal intestine 
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innate immune gene expression can be modulated by maternal supplementation 
with specific probiotic bacteria. 
Also, the maternal exposure to a variety of microbes during pregnancy can 
have an impact on the infant’s health. Maternal exposure to farm animals 
appears to protect the infant from asthma, hay fever and eczema, although 
continued exposure may be required for optimal protection (Douwes et al., 
2008; Roduit et al., 2011). In addition, antibiotic exposure during pregnancy 
has been associated with a risk of developing asthma later in childhood 
(Stensballe et al., 2013). In contrast, probiotic interventions aiming to reduce 
the risk of atopic dermatitis appear to be more effective when conducted 
perinatally compared to prenatal or postnatal interventions only (Doege et al., 
2012). However, the exact mechanisms remain unknown. 
2.5.2 Mode of delivery 
The major colonization process of the gastrointestinal tract starts at birth when 
maternal vaginal and fecal microbiota serve as inocula to the newborn child. 
During cesarean section, this direct contact is absent and the infant is exposed 
to environmental microbes instead, which can lead to disturbances in the gut 
microbiota development. Epidemiological and experimental studies have 
shown that these disturbances caused by cesarean section may be associated 
with diseases such as asthma (Sevelsted et al., 2015), inflammatory bowel 
diseases (IBD) (Sevelsted et al., 2015) and obesity (Darmasseelane et al., 
2014). 
During the first day of life, infants born vaginally have been reported to be 
predominantly colonized by bacteria associated with vaginal environment such 
as Lactobacillus, Prevotella or Sneathia spp., whereas cesarean section 
delivered infants are colonized by microbes typically found on the skin surface, 
such as Staphylococcus, Corynebacterium, and Propionibacterium spp. 
(Dominguez-Bello et al., 2010). Moreover, colonization by Lactobacillus, 
Bifidobacterium and Bacteroides has been noted to be delayed in infants 
delivered by cesarean section (Adlerberth et al., 2006; Grönlund et al., 1999). 
A recent study demonstrated that especially colonization by lactate-producing 
and -utilizing bacteria is delayed in infants born by cesarean section (Pham et 
al., 2016). Disturbances in the microbiota caused by cesarean section have been 
reported to last up to 6 months after birth (Grönlund et al., 1999). Another 
study using culture based techniques reported differences in gut microbiota 
between children born by vaginal delivery or cesarean section still at seven 
years of age (Salminen et al., 2004).  




After birth, the transfer of microbiota from mother to infant continues through 
breastfeeding. In addition to its nutritional value, breast milk contains various 
bioactive components that are thought to be protective and to supplement the 
innate immunity and have an impact on the infant gut microbiota composition 
and health (Petherick, 2010; Walker, 2010). These compounds include 
regulatory cytokines and growth factors, human milk oligosaccharides (HMO) 
and viable microbes as well as regulatory cytokines and growth factors that 
support and guide the development and maturation of the immune system. The 
gut microbiota of a breast-fed infant is typically dominated by species of 
Bifidobacterium, while formula fed infants harbour a more diverse microbiota 
containing Escherichia coli, Clostridium difficile, Bacteroides spp. and 
Lactobacillus spp. (Penders et al., 2005; Cooke et al., 2005; Bezirtzoglou et al., 
2011). 
 
2.5.3.1 Breast milk microbiome 
 
First reports of microbes in human milk date back to 1970’s, but the focus was 
on pathogenic bacteria as possible sources of infection (Carroll et al., 1979; 
Eidelman and Szilagyi, 1979). The idea about human milk as a possible source 
of commensal microbes emerged in the beginning of 2000’s (Martin et al., 
2003; Heikkilä and Saris, 2003).  
The breast milk microbiota has been described to be dominated by the phyla 
Proteobacteria and Firmicutes and the taxa Staphylococcus, Pseudomonas, 
Enterobacteriaceae, Streptococcus, Lactobacillus, Weissella and Leuconostoc 
(Cabrera-Rubio et al., 2012; Hunt et al., 2011; Urbaniak et al., 2016). In 
addition, a number of studies also suggest that breast milk contains a high 
number of bifidobacteria (Martín et al., 2009; Makino et al., 2011). 
Interestingly, the milk microbiota varies between individuals and it is affected 
by mode of delivery, possibly due to hormonal changes produced during labor, 
and maternal weight (Cabrera-Rubio et al., 2012, 2016). In addition, the milk 
microbiota seems to reflect the mother’s health status also. For instance, atopic 
mothers have been described to have a lower abundance of Bifidobacterium sp. 
in their milk compared to healthy mothers (Grönlund et al., 2007). 
The origin of bacteria in the breast milk is not entirely clear yet. At first it 
was thought that the bacteria in breast milk originate from the skin of the breast 
area. Further investigations revealed that breast milk contains bacterial species 
such as lactobacilli and bifidobacteria that are not found on skin, but rather in 
the gastrointestinal tract of the mother (Gueimonde et al., 2007; Martin et al., 
2003; Sinkiewicz and Nordström, 2005). Current belief is that bacteria may be 
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transferred from the gastrointestinal tract to the mammary gland via the so-
called entero-mammary pathway. It has been proposed that dendritic cells may 
serve as transport vehicles for the bacteria. These cells are able to penetrate the 
intestinal wall (Rescigno et al., 2001) and possibly take up non-pathogenic 
bacteria from inside the gut and feed them in the lymphatic and blood 
circulation through which they finally reach the milk producing mammary 
gland (Perez et al., 2007). Interestingly, bacteria have also been detected in 
breast tissue in non-lactating women, which could suggest that at least part of 
the microbiota resides naturally in the mammary gland (Urbaniak et al., 2014). 
 
2.5.3.2 Human milk oligosaccharides 
 
Maybe the most important factors influencing the infant’s gut microbiota 
development are the HMOs (Figure 3). The major HMO components in human 
milk are mono- and difucosyllactose, lact-N-tetraose (LNT), and their mono- 
and difucosylated derivatives as well as fucosylated lacto-N-hexaoses and 
lacto-N-octaoses (Kunz et al., 2000). However, the HMO profile of the human 
milk is unique to each mother and so far more than a hundred different HMOs 
have been identified (Kobata, 2010; Kunz et al., 2000). The genotype of an 
individual affects HMO profile which is largely dependent on the expression of 
glycosyltransferases and the secretor type, defined by the ability to encode the 
alpha1,2-fucosyltransferase FUT2 (Kobata, 2010; Kunz et al., 2000). This 
enzyme affects the Lewis blood group and controls the secretion of ABO histo-
blood group antigens at mucosal surfaces (Kelly et al., 1995; Oriol et al., 1981). 
For instance, FUT2 non-secretors, who don't have an active FUT2 allele, lack 
the oligosaccharide 2’-fucosyllactose which is the most abundant 
oligosaccharide in breast milk of secretors. Oligosaccharide amount and 
composition in milk also varies over the course of lactation. Colostrum has 
been noted to have the highest concentration with as much as 20-25 g/l of 
HMOs, whereas after maturation the HMO concentrations in breast milk are 
typically around 5-20 g/l (Chaturvedi et al., 2001; Coppa et al., 1999; Thurl et 
al., 2010). Interestingly, the oligosaccharide concentration in bovine milk has 
been reported to be very low (0.05 g/l) in comparison to human milk (Gopal 
and Gill, 2000). 
HMOs are known to act in the infant gut as substrates for specific bacteria, 
such as specific bifidobacterial species (Bode, 2012), but HMOs can also act as 
decoy molecules for pathogens (Zivkovic et al., 2011; Zopf and Roth, 1996). 
Moreover, HMOs are known to directly affect intestinal epithelial cells and 
modulate their gene expression as well as influence lymphocyte cytokine 
production (Bode, 2012). It has been also suggested that sialic acid, a 
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component of some HMOs, is an essential nutrient for brain development and 
cognition (Wang, 2009). 
The impact of HMOs on the growth of bifidobacteria has been studied 
extensively in vitro. It seems that the ability to consume HMOs is a species or 
even strain specific trait for the bifidobacteria (Ruiz-Moyano et al., 2013). 
Thus it is incorrect to refer to HMOs as “bifidogenic”. For instance, B. longum 
subsp. infantis is known to grow well in HMOs when they are offered as the 
sole carbohydrate source, whereas B. bifidum grows slower in HMOs, and B. 
longum subsp. longum and B. breve can only utilize lacto-N-tetraose (LNT), 
but not lacto-N-neotetraose (LNnT) (Asakuma et al., 2011; LoCascio et al., 
2007; Xiao et al., 2010). The genome of B. longum subsp. infantis has been 
sequenced and it revealed entire gene clusters that control the expression of 
specific glycosidases, sugar transporters and glycan-binding proteins dedicated 
to HMO utilization (Sela et al., 2008). In addition to bifidobacteria, two species 
of Bacteroides, Bacteroides thetaiotaomicron and Bacteroides fragilis, have 
been identified as consumers of HMOs (Marcobal et al., 2011). 
Despite a number of in vitro studies conducted, only a limited number of 
studies have looked at the impact of HMOs on infant gut microbiota 
composition in humans so far. It seems that the maternal FUT2 secretor status 
has an impact on the infant’s gut bifidobacterial communities with 
bifidobacteria being established earlier and more often in infants fed by 
secretor mothers (Lewis et al., 2015). A study conducted by Wang and 
coworkers (2015) showed that it is possible to some extent to predict the 
infant’s gut microbiota composition based on the mother’s milk’s  
oligosaccharide composition. Later, other groups have reported similar results 
(De Leoz et al., 2015). Interestingly, no reports have been available on the 
impact of HMOs on the breast milk microbiota composition itself. 
 




Figure 3. Basic structure of human milk oligosaccharides. 
2.5.4 Introduction of complementary foods and weaning 
The introduction of complementary foods is also an important step affecting 
the development of the gut microbiota shifting it towards a more adult-like 
microbiota. After the introduction of solid foods, the diversity of the gut 
microbiota increases and typically there is an increase in the proportion 
bacteria that are specialized in breaking down plant polysaccharides, such as 
members of the phyla Bacteroidetes and some species of Firmicutes, which 
may increase the production of SCFAs (Koenig et al., 2011). Another study 
conducted by Fallani and coworkers (2011) reported that bifidobacteria, 
enterobacteria and C. difficile and C. leptum species decrease while C. 
coccoides and C. leptum increase after weaning. However, it has been also 
suggested that actually the cessation of breast-feeding is the major driver in the 
development of an adult type microbiota instead of the introduction of solid 
foods (Bäckhed et al., 2015). Nevertheless, at 2-3 years of age, the gut 
microbiota and its functions start to resemble an adult’s microbiota and its 
activity (Koenig et al., 2011). 
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2.5.5 Geographic location 
A number of studies indicate that infants in different geographical locations 
have differences in the gut microbiota composition. It has been hypothesized 
that humans among other animals have adapted to colder climates by 
increasing their body mass (Bergmann’s rule) (Holliday and Hilton, 2010). 
Thus, some have suggested that people in the colder climates would have a 
microbiota that is associated with weight gain with an increase in the 
proportion of Firmicutes and a decrease in the proportion of Bacteroidetes 
(Suzuki and Worobey, 2014). 
Data indicates that gut microbiota composition of infants is different 
between European countries. Fallani and coworkers (2010) suggested that there 
is a north-south gradient in the microbiota composition across young 
Europeans infants: Northern European infants had higher levels of 
Bifidobacterium, Atopobium, Clostridium perfringens and Clostridium difficile, 
and lower levels of Bacteroides, Eubacterium and Lactobacillus than the 
Southern European infants. 
Differences between European and African infants have been reported also. 
Infants in Burkina Faso have been reported to have higher proportions of 
Bacteroidetes while Firmicutes and Enterobacteriaceae were under-represented 
compared to Italian infants (De Filippo et al., 2010). Another study conducted 
by Grześkowiak and coworkers (2012a) compared Malawian and Finnish 
infants. In this study, the Malawians had higher levels of bifidobacteria, 
Bacteroides-Prevotella and Clostridium histolyticum while the species 
Bifidobacterium adolescentis, Clostridium perfringens and Staphylococcus 
aureus were only detected in Finnish infants (Grześkowiak et al., 2012a). 
In both of the aforementioned studies the authors speculated that diet is most 
likely the most important factor influencing the observed differences in gut 
microbiota composition between the European and African infants. In the 
African countries, infants are typically breastfed for a longer period of time, but 
complementary foods introduced earlier. The complementary foods are often 
rich in fiber and complex carbohydrates, which the European diet often lacks, 
and these may modify the gut microbiota composition (De Filippo et al., 2010; 
Grześkowiak et al., 2012a).  
2.5.6 Probiotics, prebiotics and dietary supplements 
Gut microbiota development may be modulated by probiotics, prebiotics or 
dietary supplements. According to the definition, probiotics are live 
microorganisms that, when administered in adequate amounts, confer a health 
benefit on the host (Hill et al., 2014; FAO/WHO, 2002). For prebiotics, the 
following definition has been proposed recently: “a prebiotic is a nondigestible 
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compound that, through its metabolization by microorganisms in the gut, 
modulates composition and/or activity of the gut microbiota, thus conferring a 
beneficial physiological effect on the host” (Bindels et al., 2015). The idea 
behind the probiotic/prebiotic therapy is to modulate an unbalanced microbiota 
towards a more balanced state and thus lower the risk of disease. 
The majority of the probiotics currently used are strains from the genera 
Lactobacillus and Bifidobacterium, such as Lactobacillus rhamnosus GG and 
Bifidobacterium animalis subsp. lactis Bb12, which are maybe the most studied 
probiotics in the world. As mentioned earlier, probiotics seem to lower the risk 
of disease better when administered to the mother during pregnancy. It seems 
that the infant’s microbiota may be modulated better this way instead of 
providing the probiotic to the infant. For instance, increased levels of 
bifidobacteria have been reported in the feces of infants whose mothers 
received Lactobacillus rhamnosus GG during pregnancy (Gueimonde et al., 
2006b; Lahtinen et al., 2009). Prenatal probiotics have also been reported to 
influence the milk microbiota composition. In addition, probiotic lactobacilli 
consumed by mothers have been recovered later from milk and infant feces 
(Abrahamsson et al., 2009). 
It has been proposed that specific prebiotics, such as galacto-
oligosaccharides (GOS) and fructo-oligosaccharides (FOS), could have similar 
functionalities as HMOs, and thus be beneficial to infants who are not breastfed 
for one reason or another (Oozeer et al., 2013). However, data about prebiotic 
interventions in early life and during pregnancy is scarce compared to probiotic 
interventions. It has been reported that supplementation of infant formula with 
a mixture of GOS and FOS may protect against infections during the first six 
months of life in formula fed infants (Arslanoglu et al., 2007). There is also 
some evidence that the addition of a mixture of GOS and FOS in infant feed 
may prevent eczema in infants up to two years of age (Osborn and Sinn, 2013).  
Diet often has a poor nutritional value in developing countries, and 
malnutrition is a problem. It has been shown that the gut microbiota has a role 
in weight regulation and thus also in malnutrition (Gordon et al., 2012). More 
recent reports support the hypothesis that the source of protein in dietary 
supplements may in fact have an impact on recovery rates in children with 
(moderate acute) malnutrition (Stobaugh et al., 2016). In developing countries, 
different dietary supplements are used to fight malnourishment. However, there 
is limited information on whether these supplements impact the gut microbiota 
development. Optimally, the gut microbiota composition would be modulated 
by the supplements to promote linear growth in infants at risk of malnutrition. 
 




Figure 4. Factors that have an impact on gut microbiota development during 
early life. 
2.6 Methods to study the human microbiota 
2.6.1 Culture-dependent methods 
Human gut microbiota has been studied since the beginning of 1900 when 
Henry Tissier isolated bifidobacteria from the stool of breast-fed infants 
(Tissier, 1900). Until the 1980s, the analysis of the microbial community in 
human gut was largely dependent on the ability to grow strict anaerobes. The 
cultured isolates were then identified and characterized by different phenotypic 
methods. However, this allowed only a limited view of the human gut 
microbiota since only a minority (30-40%) of gut bacteria can be cultured even 
by the most advanced culturing techniques today (Rettedal et al., 2014; Lagier 
et al., 2012). When the culture-independent molecular methods revolutionized 
the gut microbiota studies in 1980s and 1990s, it became clear that the 
taxonomic and phylogenetic diversity of the human gut microbiota had been 
enormously underestimated (Namsolleck et al., 2004). Nevertheless, it is 
important to remember that the culture method gives important information on 
the viability and culturability of various microorganisms and their complex 
relations in gut microbiota assessment. 
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2.6.2 Polymerase chain reaction, the dawn of molecular 
methods 
Almost all molecular methods used in microbiota studies today are based on 
the amplification of DNA by polymerase chain reaction (PCR). PCR, as we 
know it today, was invented in the 1980s by Kary Mullis and colleagues at 
Cetus Corporation in California (Bartlett and Stirling, 2003). PCR allows the 
amplification of a single or a few copies of a piece of DNA exponentially 
generating millions of copies of the desired DNA sequence, which can be then 
analyzed using various methods. In microbiology typically the 16S rRNA gene 
is amplified and sequenced because it is highly conserved within prokaryotes, 
but the sequence differs between organisms of other genera and species (Woese 
et al., 1990). 
Today, DNA-based methods can be divided into targeted amplicon studies 
and the more recent shotgun metagenomic studies. The former mentioned 
studies focus on specific known marker genes, such as the 16S rRNA gene, and 
primarily gives taxonomically informative data. The metagenomic studies are 
indirect and take into account the whole microbial community, which can give 
information about the functional potential of the human microbiome.  
However, molecular methods based on PCR do not come without limitations. 
PCR is prone to the so-called PCR induced bias (Polz and Cavanaugh, 1998). 
Especially in microbiota studies, this can cause noticeable error. Relative 
abundancies can increase or decrease due to differences in the reaction 
efficiency. For instance, reaction efficiency is typically reduced if the template 
DNA has a high GC content. Sequence-based techniques can also totally miss 
minor but clinically relevant populations, including pathogenic bacteria such as 
Salmonella Typhi, Tropheryma whipplei and Yersinia enterocolitica due to the 
so called depth bias (Lagier et al., 2012). 
Prior to PCR, the DNA has to be extracted from the microbes. This step can 
also influence the final results. Due to the cell-wall structure of gram-positive 
microorganisms, poor yield of DNA is common from these cells if they are not 
lysed properly. Better yield can be achieved by including a step where the cells 
are physically disrupted with bead-beating for instance (Nylund et al., 2010). 
However, this may cause DNA shearing and thus the method has to be properly 
optimized (Miller et al., 1999; Yuan et al., 2012). 
In microbiota studies, the results in PCR-based methods may also be 
strongly influenced by PCR primer choice. For example, it has been shown that 
some widely utilized primers targeting the 16S rRNA may not be able to 
amplify some bacterial DNA, such as that from Actinobacteria, and therefore 
the primers should be modified to overcome this problem (Walker et al., 2015). 
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2.6.3 Polymerase chain reaction denaturing gradient gel 
electrophoresis (PCR-DGGE) 
In the beginning of 1990s, denaturing gradient gel electrophoresis (DGGE) was 
introduced for the analysis of the diversity of complex microbial ecosystems 
(Muyzer et al., 1993). Together with temperature gradient gel electrophoresis 
(TGGE), this method remained the golden standard in the gut microbiota 
community analysis until the next-generation sequencing methods emerged. 
DGGE is based on the mobility of partially melted DNA molecules, for 
instance the 16S rRNA gene, in polyacrylamide gels (Muyzer and Smalla, 
1998). Partially melted DNA molecules have a decreased mobility compared to 
completely helical forms of the molecule. The gel has an increasing denaturing 
gradient in which the melted strands fragment completely into single strands 
and then come to a stop. Mobility of the DNA fragment in DGGE is dependent 
on its GC content: DNA molecules with higher GC content are more stable and 
thus denature slower and travel faster and further in the polyacrylamide gel. 
This makes it possible to separate DNA fragments of the same length but with 
varied sequences providing a semi-quantitative community fingerprint of the 
bacterial species present in the sample. These fragments can be also isolated 
from the DGGE gels for identification by sequencing. 
One of the strongest points of DGGE is that it can be used to analyze 
multiple samples simultaneously. Due to this, DGGE can be used for 
comparative purposes; for instance, comparing the gut microbiota of a person 
with a disease to a healthy one. Although some think that high-throughput 
methods have made this technique obsolete, it is still utilized in gut microbiota 
research due to its low cost, reliability, reproducibility and ease of use. 
2.6.4 Quantitative PCR 
While PCR can be used to detect bacterial DNA in given samples, used alone it 
is unreliable for quantification. qPCR is similar to standard PCR, but the 
reaction mixture includes a compound that fluoresceces when bound to double-
stranded DNA. When the fluorescence is measured in each PCR cycle, it can 
be used to estimate the amount of DNA present in the test sample when 
compared to a standard curve obtained from dilution series of reference DNA 
(Carey et al., 2007). qPCR can be used to quantitate bacterial load accurately 
up to strain level. However, if the copy numbers of 16S rRNA gene are counted 
for instance, it must be kept in mind that some bacterial genomes contain 
multiple copies of this gene, which may affect the end result (Farrelly et al., 
1995; Nadkarni et al., 2002).  
For gut microbiota research, quantitative PCR (qPCR) was combined with 
primers targeting different bacterial groups (Gueimonde et al., 2004; Rinttila et 
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al., 2004). This method is still one of the most accurate methods available for 
microbiota analysis. It also allows the analysis of bacteria whose relative 
abundance is low and that are often lost in high-throughput methods such as 
next-generation sequencing. However, qPCR can be only used to target already 
known microbial species and is therefore often complemented with some other 
method. Due to the high accuracy of this method, it still has a wide variety of 
applications in human microbiota studies. 
2.6.5 Next-generation sequencing of 16S rRNA gene 
Before the introduction of the so-called next-generation sequencing 
technologies, direct sequencing of the 16S rRNA genes from complex 
microbial communities was very cumbersome and costly. The 16S rRNA gene 
sequences had to be amplified with universal primers, cloned into vectors, 
transformed into E. coli, then colonies were picked for sequencing, purification 
of plasmid and bidirectional sequencing (Tringe and Rubin, 2005).  
The next-generation sequencing technologies have allowed the sequencing 
of massive numbers of DNA templates at the same time in the same reaction 
set-up. The 454 sequencing (Roche Diagnostics GMBH Ltd, Mannheim, 
Germany) was one of the first technologies that allowed the sequencing of 
amplified DNA fast and at a lower cost (Margulies et al., 2005). This technique 
was quickly adapted for microbial community analysis by several groups 
(Andersson et al., 2008; Sogin et al., 2006; McKenna et al., 2008) allowing a 
high resolution profiling of microbial communities in complex environments 
such as the gut microbiota. Since then, other commercially available 
technologies have emerged from other companies as well, the major ones being 
Illumina (Illumina, San Diego, CA, USA) and SOLiD (Life Technologies, 
Carlsbad, CA, USA). 
Next-generation sequencing has various advantages such as phylogenetic 
identification, detection of unknown bacteria, the ability to collect quantitative 
data and speed. Unfortunately, sequencing of the whole 16S rRNA gene is not 
widely available yet and thus these technologies are limited to genus level 
analysis in microbiome studies. The fragment length, PCR bias and choice of 
16S rRNA gene region influences the community diversity estimates by next-
generation sequencing (Youssef et al., 2009). For instance, shorter amplicon 
lengths may result in relatively higher diversity estimates compared to longer 
fragments (Engelbrektson et al., 2010). Thus, the choice of the hypervariable 
region of the 16S rRNA gene is highly important (Kim et al., 2011). Due to 
these methodological differences, it may often be difficult to compare 
community diversity results across different studies.  
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The next-generation sequencing technologies have become a staple in 
microbiota research. Nevertheless, the studies based on the 16S rRNA gene can 
only give us information about phylogenetics, not what the bacteria actually do 
in the gut. For this purpose, more thorough analysis of bacterial genomes, such 
as metagenomics, is needed. 
2.6.6 Metagenomics 
While the research based on 16S rRNA gene sequence attempts to answer the 
question “who’s there?”, metagenomics may be used to answer the additional 
questions of “what can they do?”, “what are they doing?”, and “what is the 
genetic potential of the non-cultured bacterial fraction of the gut microbiota?”. 
Metagenomics has been described as a genomic analysis applied to all 
microorganisms of an ecosystem without previous identification (Lepage et al., 
2013). Metagenomics was first described by Handelsman and Rodon in 1998 
and used in the analysis of aquatic and soil ecosystems (Handelsman et al., 
1998; Rondon et al., 1999). 
The emergence of next-generation technologies has made metagenomics 
more cost-effective. Nowadays it is possible to directly shotgun sequence the 
metagenomic DNA content of an ecosystem. This means that the DNA of a 
mixed DNA sample, for instance from gut microbiota, is randomly fragmented 
and then these fragments are sequenced and the overlapping sequences are 
reconstructed to assemble them into a continuous sequence (Fraher et al., 2012). 
This data then allows the assessment of genetic diversity and functions of the 
gut microbiota. 
Differences in sequencing platforms, DNA preparation methods and the 
complexity of the samples studied can cause different or biased observations 
(Poretsky et al., 2014). Another fallback of metagenomics is that it does not 
permit monitoring the activity or gene expression of the microbiota (Lepage et 
al., 2013). For example, it has been shown in marine ecosystems that microbial 
presence and activity are not linked together since the most expressed genes are 
not the most represented ones within the metagenome (Frias-Lopez et al., 
2008). To overcome this fallback, the messenger RNA (mRNA) sequences 
from the microbial community should be analyzed. This method is known as 
metatranscriptomics, which again has its own challenges and limitations.  
Metagenomics can be combined with other “omics” technologies. In 
addition to the aforementioned, metatranscriptomics, metaproteomics (protein 
mapping profile) and metabolomics (metabolic profile) may provide additional 
useful data. For instance, metagenomics combined with metabolomics has been 
used to identify the role of microbiota in dietary phospholipid metabolism, 
contributing to atherosclerosis (Wang et al., 2011). 
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Table 1. Advantages and disadvantages of common methods used in gut 
microbiota analysis  
Method Description Advantages Disadvantages 
Culturing Isolation of bacteria on selective media 
Cheap, semi-
quantitative, 





most of the human 
gut microbes cannot 
be cultured by 
today's techniques 
DGGE/TGGE 
Gel separation of 16S rRNA 




bands can be 
excised for 
identification 





Amplification and quantification 
16S rRNA. Reaction mixture 
contains a compound that 





PCR bias, laborious 
if many different 
bacteria/bacterial 




Massive parallel sequencing of 
partial 16S rRNA amplicons with 









Massive parallel sequencing of 
the whole genome with 454 









2.7 Future perspectives 
During the past decade, the development of high-throughput technologies has 
caused an avalanche of metagenomic data. The cost effectiveness has increased 
significantly during recent years and will continue to increase in the future. 
Together with exponential increase in computational power a more thorough 
analysis of the gut microbiota at a lower cost will be available to almost 
everyone. Moreover, the research will most likely expand into studying the 
metatranscriptome and metaproteome of the microbiota. Therefore, data 
analysis and interpretation will have an even bigger role than today. 
Despite the advances in techniques used in microbiota research, a lot 
remains to be uncovered about the role of human microbiota in human health. 
The information we have today about this subject is mainly based on 
association studies and a shift to studying mechanisms and causality is needed 
for true understanding of the role of gut microbiota in health and disease 
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(Waldor et al., 2015). Moreover, since microbes interact with each other in the 
gut, it will be important to identify bacterial genomes that work as functional 
groups (guilds) in the gut (Zhang et al., 2015). Understanding the mechanistic 
bases for interaction between microbial communities and their hosts will most 
likely reveal new therapeutic approaches aiming to modulate the gut microbiota 
to treat non-communicable diseases, such as allergic, autoimmune and anti-
inflammatory disorders, as well as obesity. 
Finally, it must not be forgotten that there are also other microorganisms in 
the intestine in addition to bacteria that may have a role in human health. In 
fact, it has been noted that bacteriophages outnumber bacterial cells by tenfold 
in the human gut (Dutilh et al., 2014). Similar to gut bacteria, gut viromes have 
been shown to be specific for individual (Reyes et al., 2010) and they seem to 
respond to diet also (Minot et al., 2011). However, the impact of the virome on 
host health remains to be elucidated. In addition to viruses, the role of parasites 
in human health has been discussed recently and it has been suggested that lack 
of some specific helminths for instance might be associated with risk 
developing of IBD (Ramanan et al., 2016). 
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3 AIMS OF THE STUDY 
The primary aim in the present study was to characterize the potential 
microbiota transfer from mother to infant and uncover factors, such as 
geographic location and diet, that affect microbiota development in early 
infancy. 
 
The specific aims were: 
 
1. To evaluate the specificity of two Lactobacillus rhamosus GG specific 
primer sets (I). 
 
2. To analyze gut Lactobacillus microbiota development in a developing 
country and to compare it to a westernized country (II). 
 
3. To study the impact of lipid-based nutrient supplements with different 
sources of protein on the development of Bifidobacterium microbiota in 
Malawian infants (III). 
 
4. To characterize the microbial populations in placenta, amniotic fluid and 
colostrum and to elucidate their role as the initial inoculum for the intestinal 
microbiota (IV). 
 
5. To assess whether human milk oligosaccharides affect the human milk 
microbiota composition (V). 
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4 MATERIALS AND METHODS 
4.1 Materials, subjects and study design 
4.1.1 Evaluation of L. rhamnosus GG strain specific primers (I) 
In study I, 41 strains of L. rhamnosus, including L. rhamnosus GG and the L. 
rhamnosus type strain, were used to evaluate two primer sets reported to be L. 
rhamnosus GG strain specific (Ahlroos and Tynkkynen, 2009; Brandt and 
Alatossava, 2003). L. rhamnosus GG (= ATCC53103) was used as a positive 
control and obtained from the American Type Culture Collection (Manassas, 
Virginia). The type strain of L. rhamnosus, DSM 20021T, obtained from the 
German Collection of Microorganisms and Cell Cultures (DSMZ, 
Braunschweig, Germany), was used as a negative control. The rest of the L. 
rhamnosus strains used in study I were obtained from the Belgian Coordinated 
Collection of Microorganisms/LMG (Gent, Belgium). The LMG strains were 
dairy and human clinical isolates identified as L. rhamnosus originating from 
different countries. All L. rhamnosus strains were routinely grown in MRS 
broth (Oxoid Ltd., Basingstoke, Hampshire, England) at 37 °C overnight. 
 
Figure 5. Study I design 
4.1.2 Lactobacillus microbiota of Malawian and Finnish infants 
(II) 
In study II, the populations consisted of healthy 6-month-old infants living in 
rural Malawi (n = 44) and Southwestern Finland (n = 31) (Figure 6). The 
Malawian infants were enrolled for a clinical trial assessing the impact of 
selected dietary interventions on early childhood growth (identifier: 
NCT00524446). In Finland, the infants were participants of a prospective 
randomized study in Turku and nearby areas in Southwestern Finland 
(identifier: NCT00167700). Infants and their mothers included in the present 
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study did not receive probiotics or prebiotics. Malawian and Finnish infants 
represented typical infants consuming typical diets for each area.  
 
 
Figure 6. Study II design 
4.1.3 Impact of dietary intervention on bifidobacterial 
populations of Malawian infants (III) 
Subjects of the study III represent a sub-population of the Lungwena Child 
Nutrition Intervention Study (LCNI-5). The study participants were healthy 
infants who met the following inclusion criteria: age 5.5 – 6.5 months, 
residence in the study area, and available informed consent from at least one 
guardian. An additional inclusion criterion was the availability of a fecal 
sample at six and twelve months of age. The exclusion criteria were as follows: 
weight-for-length (WFL) 80 % of the World Health Organization (WHO) 
reference median, presence of edema, severe illness warranting hospitalization 
on the enrollment day, history of peanut allergy, concurrent participation in 
another clinical trial and any symptoms of food intolerance within 30 min of 
ingesting a 5 g test dose of lipid-based nutrient supplement (either milk or soy-
based) used in the trial. Of the total 840 participants in the main trial, 160 were 
selected to the current sub-study (Figure 7). The study III infants were 
randomly assigned to one of four intervention schemes for a 6-month period 
(Figure 7). Infants either received 71g/day of micronutrient-fortified corn-soy 
blend (CSB), 54 g/day of micronutrient-fortified lipid-based nutrient 
supplements (LNS) with milk protein base (milk-LNS) or 54 g/day of 
micronutrient-fortified LNS with soy protein base (soy-LNS) between 6 and 12 
months of age. 




Figure 7. Study III design 
 
4.1.4 Microbial contact in utero and in early infancy (IV) 
The study IV samples were collected from subjects participating in a 
randomized double-blind placebo-controlled clinical trial (identifier: 
NCT00167700), which aimed to assess the impact of probiotic modulation on 
maternal microbial contact in late pregnancy. Pregnant women, who were 
scheduled to undergo cesarean section after 37 weeks of gestation, were 
recruited to obtain placenta samples without risk of contamination taking place 
during delivery. Mothers with conditions, which might affect placental and 
fetal physiology (e.g. pre-eclampsia, intrauterine growth retardation, fetal 
anomalies, onset of labour, asphyxia) or contaminate the placenta (rupture of 
membranes, vaginal delivery, infection), were excluded from the study. 
Amniotic fluid, placenta, meconium, colostrum, infant feces and maternal feces 
samples were available from 15 mother-infant pairs and included in the study 
IV (Figure 8). 




Figure 8. Study IV design 
4.1.5 Impact of human milk oligosaccharides on human milk 
microbiota (V) 
The study V participants were from the same randomized, double-blind 
placebo-controlled trial as the study IV. For study V, colostrum samples from 
eleven mothers after full-term cesarean section were available for analysis 
(Figure 8).  
 
Figure 9. Study V design 
4.2 Methods 
4.2.1 Sample collection (II-V) 
In study II, the Finnish fecal samples were collected, stored frozen and 
transported to the laboratory in the Functional Foods Forum, University of 
Turku, Finland, and stored at -70 °C until analysis. For studies II and III, fecal 
samples from Malawian infants were collected at home by parents, then 
brought to the clinic and collected by lab technicians, which took 2-4 hours in 
total. The samples were stored at -20 °C in the study site and later at a central 
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laboratory in Mangochi at -40 °C until being transported from Malawi to 
Finland and stored at -70 °C until analysis. In study IV amniotic fluid and 
placenta samples were obtained during sterile cesarean section and stored at -
80 °C. Meconium (0-2 d) and infant fecal samples (3-4 d) were collected from 
diapers after they had been passed. Meconium, infant and maternal fecal 
samples were collected in sterile plastic containers, refrigerated and processed 
without further delay. In study IV and V, colostrum samples were collected in 
the maternity hospital using milk produced within 24 hours of delivery. The 
mothers were given written instructions for standardized collection of samples 
in the mornings and the samples were stored at -20 °C until analyzed. 
4.2.2 DNA extraction (I-V) 
4.2.2.1 DNA extraction from reference strains (I) 
 
In study I, the DNA was extracted from 1 ml of the cultured cells using the 
method described by Endo and coworkers (2007). In short, the cells were 
washed twice with 1 ml of TE buffer (10mM Tris-HCl, 1 mM EDTA; pH 8.0) 
and then resuspended in a solution containing 250 μl of extraction buffer (100 
mM Tris-HCl, 40mM EDTA; pH 9.0), 50 μl of 10 % sodium dodecyl sulfate, 
and 150 μl of benzyl chloride. In addition, 100 mg of glass beads (0.1 mm in 
diameter) were added to the suspension and the mixture was beaten three times 
for 30 s with FastPrep-24 (FP120-230, Bio 101 ThermoSavant, Holbrook, NY). 
Next, 150 μl of 3 M sodium acetate was added to the beaten sample and then 
the sample was kept on ice for 15 min. Then, the sample was centrifuged at 
15000×g for 10 min after which the supernatant was transferred to a new tube 
and DNA was precipitated with isopropanol. The precipitated DNA was 
suspended in 50 μl of TE buffer. DNA yield was measured with NanoDrop 
ND-1000 spectrophotometer (NanoDrop® Technologies, Wilmington, DE, US) 
and the DNA was diluted to 10 μg/μl prior to use. 
 
4.2.2.2 Manual DNA extraction utilizing the Qiagen column (II, IV and V) 
 
In study II DNA was extracted from the fecal samples using QIAmp DNA 
Stool Mini Kit (Qiagen, Venlo, The Netherlands) as described by Grzeskowiak 
and coworkers (2012). Briefly, fecal samples were weighed (0.5 g), diluted 
1:10 (w/v) with PBS buffer (130mM sodium chloride, 10 mM sodium 
phosphate, 0.05 % cysteine, pH 7.2) and homogenization was performed by 
thorough agitation in a vortex. Next, aliquots of these dilutions were used for 
DNA extraction with the QIAmp DNA Stool Mini Kit following the 
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manufacturer’s instructions. In studies IV and V, instead of vortexing, the 
samples were homogenized using repeated bead-beating with FastPrep-24 
(FP120-230, Bio 101 ThermoSavant, Holbrook, NY). 
 
4.2.2.3 Semi-automated DNA extraction using KingFisher (III) 
 
In study III, the samples were pre-treated with repeated bead-beating and DNA 
was extracted using InviMag Stool DNA kit (Stratec Molecular, Berlin, 
Germany) and automated KingFisher DNA extraction system (Thermo Fisher 
Scientific Oy, Vantaa, Finland), as previously described (Nylund et al., 2010). 
Briefly, fecal samples were weighted (0.1-0.125 g) and mixed with 0.5 ml of 
lysis buffer P, glass-beads and glass-sand (0.25g of glass-sand, 0.1 mm and 4 
pieces of glass-beads, 1.5 mm) in 2 ml screw cap tube. Homogenization and 
mechanical cell disruption was performed by two rounds of bead-beating 
(treatment time 3 min) with FastPrep-24 (FP120-230, Bio 101 ThermoSavant, 
Holbrook, NY) and heat treatment (95 C, 15 min). 
4.2.3 Lactobacillus rhamnosus GG strain-specific PCR (I and II) 
Two different L. rhamnosus GG specific primer sets were used in study I: the 
first set targeted a putative transposase gene (Ahlroos and Tynkkynen, 2009) 
and the second a phage-related gene of L. rhamnosus GG (Brandt and 
Alatossava, 2003). For each primer set, the reaction mixture and the 
amplification of DNA was done as previously described (Ahlroos and 
Tynkkynen, 2009; Brandt and Alatossava, 2003). Successful amplification was 
verified by subjecting the PCR products to gel electrophoresis in 1.0% agarose, 
followed by ethidium bromide staining. 
4.2.4 Fingerprinting analysis (I) 
Rep-PCR, RAPD and ERIC PCR fingerprinting were carried out to distinguish 
the different L. rhamnosus strains from each other in study I. The rep-PCR was 
carried out using the primers (GTG)5 and a primer set of REP1R-I and REP2-I. 
The preparation of reaction mixture and amplification of DNA was performed 
as previously described (Gevers et al., 2001). For RAPD, six different primers 
(C0540, 1251, OPA-03, D, E, and F) were used, and the reaction mixture and 
amplification of DNA was performed as previously described by Endo & 
Okada (Endo and Okada, 2005). Finally, ERIC-1 and ERIC-2 were used for the 
ERIC PCR, for which the preparation of the reaction mixture and amplification 
of DNA were performed using the method described by Ventura et al. (2003). 
The amplification products were subjected to gel electrophoresis in 1.0% 
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agarose, followed by ethidium bromide staining. Electrophoresis images were 
imported to Bionumerics software version 6.6 (Applied Maths, Belgium) for 
further analysis. 
4.2.5 Denaturing gradient gel electrophoresis (DGGE) (II and 
IV) 
PCR-DGGE was used to characterize the microbiota in fecal samples in studies 
II and IV, and in breast milk, placenta and amniotic fluid samples in study IV. 
The primer set Lac1 and Lac-GC (Walter et al., 2001) was used in study II to 
analyze the Lactobacillus group community in the fecal samples. The reaction 
mixture was prepared as previously described (Endo and Okada, 2005) and the 
thermal cycling was conducted according to Walter et al. (2001). In study IV, 
total bacteria primers F357-GC and R518 (Muyzer et al., 1993) were used and 
the reaction mixture was prepared and the thermal cycling conducted as 
described by Endo et al. (2008). Successful amplification was confirmed by gel 
electrophoresis in 1.0% agarose.  
The DGGE analysis was performed using the DCode system (Bio-Rad 
Laboratories, Hercules, CA) according to the method described by Endo et al. 
(2007) (Endo et al., 2007). For lactobacilli, a denaturing gradient of 35% to 50% 
was used and the electrophoresis was performed at a constant voltage of 23 mA 
for 16 hours. For total bacteria, a denaturing gradient of 35% to 75% was used 
instead and the electrophoresis was conducted at a constant voltage of 28 mA 
for 16 h. The gels were stained, unknown bands were excised and sequenced 
according to the method described by Endo et al. (2007). Digitalized DGGE 
images were imported to Bionumerics software version 6.6 (Applied Maths, 
Belgium) for further analysis. 
4.2.6 DNA fingerprinting and DGGE images processing (I, II, 
IV) 
In studies I, II and IV, electrophoresis images were imported to Bionumerics 
software version 6.6 (Applied Maths, Belgium) for normalization and band 
detection. Band search and band matching were conducted using a band 
tolerance of 1% as implemented in Bionumerics. Bands and band matching 
were manually checked and corrected when deemed necessary.  
In studies II and IV, the band presence/absence and intensity matrices were 
exported from Bionumerics and imported to R version 3.1.2 (R Core Team, 
2015) for further analysis. Number of bands present in the DGGE profile was 
used as a measure of richness for the samples, and the Shannon diversity index, 
H’, was calculated using the equation H’ = -ΣPi ln (Pi). Pi is the importance 
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probability of the bands in a gel lane is calculated as Pi = ni/N, in which ni, is 
the intensity of band I and N is the sum of intensities of all bands in the 
densitometric profile. 
4.2.7 Quantitative polymerase chain reaction (qPCR) analysis 
of microbiota (II, III and V) 
Quantitative PCR was used to characterize the fecal and breastmilk microbiota 
in studies II, III, and V using group- and species-specific primers. PCR 
amplification and detection were performed with an ABI PRISM 7300-PCR 
sequence detection system (Applied Biosystems, Foster City, CA). The 25 μl 
reaction mixture composed of Power SYBR Green PCR Master Mix (Applied 
Biosystems), 1 μL of each of the primers at a concentration of 0.2 mol/l and 1 
μl of template DNA. The fluorescent products were detected in the last step of 
each cycle and a melting curve analysis was performed after the amplification 
to distinguish the targeted PCR product from the nontargeted ones. Bacterial 
concentration in each sample was determined by comparing the Ct values 
obtained from standard curves. The standard curves were made from serial 
dilutions of DNA isolated from a known amount of each pure culture of the 
different reference strains.  
The following reference strains were used: B. longum DSM 20219 (also for 
Bifidobacterium genus), B. catenulatum DSM 20224, B. bifidum DSM 20456, 
B. lactis DSM 20606, B. infantis DSM 20090, B. adolescentis DSM 20083, B. 
breve DSM 20213, Akkermansia muciniphila ATCC BAA-835, S. aureus DSM 
20231, C. coccoides DSM 935T, C. leptum DSM753T, L. rhamnosus 
DSM20021T, Streptococcus thermophilus CECT 986, Enterococcus faecalis 
CECT 481, and Escherichia coli K-12 (for total bacteria). Bacteroides fragilis 
DSM 2151. The sequences and annealing temperatures of the primers used for 
qPCR in studies II, III and V are presented in Table 2. 
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Table 2. Primers used in qPCR analysis in studies II, III and V 
 




Total bacteria AACGCGAAGAACCTTAC 58 Muyzer et al. 1993 
CGGTGTGTACAAGACCC 
Bifidobacterium spp. CTCCTGGAAACGGGTGG 60 Matsuki et al. 2002 
GGTGTTCTTCCCGATATCTACA 
B. adolescentis GGATCGGCTGGAGCTTGCTCCG 63 Rinne et al. 2005 
 CCCCGAAGGCTTGCTCCCAGT 
B. longum group TTCCAGTTGATCGCATGGTCTTCT  65 Rinne et al. 2005 
GGCTACCCGTCGAAGCCACG  
B. breve AATGCCGGATGCTCCATCACAC 62 Rinne et al. 2005 
GCCTTGCTCCCTAACAAAAGAGG 
B. bifidum TGACCGACCTGCCCCATGCT 61 Rinne et al. 2005 
CCCATCCCACGCCGATAGAAT  
B. catenulatum GCCGGATGCTCCGACTCCT 64 Rinne et al. 2005 
ACCCGAAGGCTTGCTCCCGAT 
Staphylococcus spp. GGCCGTGTTGAACGTGGTCAAATCA 58 Martineau et al. 2001 
TIACCATTTCAGTACCTTCTGGTAA 
Staphylococcus aureus NUC GCGATTGATGGTGATACGGTT 55 Fang & Hedin 2002 
AGCCAAGCCTTGACGAACTAAAGC 
Streptococcus group GAAGAATTGCTTGAATTGGTTGAA 62 Collado et al. 2009 
GGACGGTAGTTGTTGAAGAATGG 
Lactobacillus group (Study II) AGCAGTAGGGAATCTTCCA 58 Rinttila et al. 2004 
CACCGCTACACATGGAG 
Lactobacillus group (Study V) GGAAACAG(A/G)TGCTAATACCG 61 Heilig et al. 2002 
CACCGCTACACATGGAG 
Enterococcus spp. ACTCGTTGTACTTCCCATTGT 62 Rinttilä et al. 2004 
CCTTATTGTTAGTTGCCATCATT 
Akkermansia muciniphila CAGCACGTGAAGGTGGGGAC 60 Collado et al. 2007 
CCTTGCGGTTGGCTTCAGAT 
Bacteroides-Prevotella group ATAGCCTTTCGAAAGRAAGAT  50 Matsuki et al. 2002 
CCAGTATCAACTGCAATTTTA 
Clostridium cluster XIVa - XIVb AAATGACGGTACCTGACTAA 53 Matsuki et al. 2002 
CTTTGAGTTTCATTCTTGCGAA 
Clostridium cluster IV GCACAGCAGTGGAGT 60 Matsuki et al. 2002 
  CTTCCTCCGTTTTGTCAA     
4.2.8 Bacterial culture from placenta and amniotic fluid 
samples and identification of bacterial isolates (IV) 
Placenta samples were kept under anaerobic conditions (AnaeroGen, Oxoid, 
Hampshire, United Kingdom) and analyzed in less than 2 hours to avoid 
alterations in bacterial viability. The placenta tissue specimens were 
homogenized in 200 μl of a phosphate-buffered saline (PBS) solution by 
pipetting and thorough agitation in a vortex. Each homogenized sample was 
randomly plated on different culture media (100 μl). The PBS solution used in 
the homogenization was plated as a negative control. The following media 
were used: Gifu anaerobic medium (GAM agar, Nissui Pharmaceutica Co., 
LTD., Tokyo, Japan) and LB medium (MP Biomedicals, LLC, France). The 
plates were incubated under anaerobic conditions at 37 °C for 48-72 h. 
All viable and cultivable bacteria recovered were isolated and re-streaked 
onto the same agar media. For preliminary identification, traditional 
microbiological methods were used, including analysis of colony and cellular 
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morphology and Gram staining. Next, the isolates were grown in the same 
isolation broth media and harvested at the late log growth phase and DNA was 
extracted using the QIAmp DNA Stool Mini Kit (QIAgen) following 
manufacturer’s instructions. DNA from each isolate was amplified with 16S 
rRNA gene targeting primers (968f and 1401r). The primer sequences and 
annealing temperatures have been published elsewhere (Nübel et al., 1996). 
The amplification products were subjected to gel electrophoresis in 1.0% 
agarose gels, purified using Gel Band DNA purification kit (GE Healthcare, 
Buckinghamshire, UK), and sequenced in an ABI Prism-3130XL genetic 
analyzer (Applied Biosystems). Search analyses to determine the closest 
relatives of the partial 16S rRNA gene sequences retrieved were conducted in 
GenBank using Basic Local Alignment Search Tool (BLAST) algorithm, and 
sequences with more than 99% similarity were considered to be of the same 
species. 
4.2.9 454 Pyrosequencing (IV) 
Pyrosequencing was used in study IV to characterize the bacterial communities 
in fecal, meconium, colostrum, placenta and amniotic fluid samples. A 
barcoded primer set based on universal primers 27F and 533R was used to 
amplify a 500bps long part of the 16S rRNA gene covering the hyper-variable 
regions V1 to V3 (V1-V3). The thermal cycling was carried out using a 
KAPA-HiFi polymerase (Kapa Biosystems, INC., Wilmington, MA) with an 
annealing temperature of 52 °C and 30 cycles. Purified PCR products were 
pooled in equimolar amounts according to manufacturer’s instructions, and 
submitted for pyrosequencing using the Genome Sequencer FLX Titanium 
Series (454 Life Science, Branford, USA). All of the procedures followed 454 
Roche protocols (454 Life Science). 
From the resulting raw data set provided by pyrosequencing, low quality 
sequences and sequences having a length shorter than 100 nucleotides were 
filtered out. Moreover, chimeric sequences were removed using UCHIME 
software (Edgar et al., 2011). A dereplicate request on the QIIME pipeline (v. 
1.8) commands with default parameters was used for identifying representative 
sequences for each operational taxonomic unit (OUT) generated from the 
complete linkage clustering with a 97% similarity and aligned to fully-
sequenced microbial genomes (Green Genes 13_8 database). 
To estimate diversity conservatively and reduce noise in patterns of beta 
diversity, singleton OTUs were removed prior to community analysis. Alpha 
diversity indices were determined from rarefied tables using the Shannon-
Wiener index for diversity, the Chao1 index for richness and Observed Species 
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(number of unique OTUs) and Phylogenetic Distance (PD_whole) were also 
determined. Most of the samples reached a plateau suggesting sufficient 
coverage of the microbes present in the samples. Microbial Beta-diversity 
between samples was evaluated and computed from the previously constructed 
OTU table using UniFrac, a phylogenetic distance metric that measures 
community similarity based on the degree to which pairs of communities share 
branch length in a common phylogenetic tree (Lozupone et al., 2011). 
4.2.10 High-performance liquid chromatography analysis of 
human milk oligosaccharides (V) 
Human milk oligosaccharide analysis was performed as previously described at 
the University of California, San Diego, CA, USA (Alderete et al., 2015). 
Raffinose was added to each milk sample as an internal standard for absolute 
quantification. The following HMOs were detected based on retention time 
comparison with commercial standard oligosaccharides and mass spectrometry 
analysis: 2’-fucosyllactose (2’-FL), 3-fucosyllactose (3’-FL), 3’-sialyllactose 
(3-’SL), lacto-N-tetraose (LNT), lacto-N-neotetraose (LNnT), lacto-N-
fucopentaose (LNFP) I, LNFP II, and LNFP III, sialyl-LNT b (LST b) and LST 
c, difucosyl-LNT (DF-LNT), disialyl-LNT (DS-LNT), fucosyl-lacto-N-
hexaose (FLNH), difucosyl-lacto-N-hexaose (DFLNH), fucosyl-disialyl-lacto-
N-hexaose (FDSLNH) and disialyl-lacto-N-hexaose (DSLNH). Secretor status 
was defined by the presence of 2’-FL or LNFP. 
4.2.11 Statistics 
Statistical analysis was performed using IBM SPSS version 21.0 (Studies II 
and IV) and R versions 3.1.2 (Study II and IV) and 3.2.2 (Studies III and V) 
(R Core Team, 2015). 
 
Study I: 
In study I, all fingerprinting data were combined to make a compositional data 
set. Next, a dendrogram was constructed from this composite data using Dice 
coefficients with the unweighted pair-group method using arithmetic averages 
(UPGMA) clustering method as implemented in Bionumerics software version 
6.6 (Applied Maths, Belgium). 
 
Study II:  
The Lactobacillus group bacterial counts (log 16S rRNA gene copies g-1) 
assessed by qPCR were expressed as means with 95% confidence interval. 
Independent samples t test was used to assess differences in means of the 
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bacterial counts between Malawian and Finnish infants. Richness in the 
samples was not normally distributed and is thus presented as medians with 
interquartile range (IQR) and analyzed using the Mann-Whitney U test. The 
Shannon diversity indices were normally distributed and are expressed as 
means with 95% confidence intervals (CI) and analyzed by independent 
samples t test. Fisher exact test was used to determine statistical difference in 
the prevalence of each band class between the Malawian and Finnish infants. 
Band classes identified as the same species were combined. 
Cluster analysis of the DGGE patterns was performed by the UPGMA based 
on the Pearson correlation similarity coefficient as implemented in 
Bionumerics software version 6.6 (Applied Maths, Belgium). Principal 
component analysis based on Euclidean distances was performed based on the 
DGGE fingerprints using the R function prcomp. The first 2 principal 
components were used to generate a 2-dimensional scatter plot. 
PERMANOVA analysis was performed using the adonis function of the vegan 
R software package (Oksanen et al., 2015), where a euclidean distance matrix 
was calculated using 999 permutations.  
 
Study III: 
Bacterial counts were not normally distributed and therefore non-parametric 
methods were used for the analysis. Bacterial detection rates are presented as 
percentages (%) and counts (log gene copies g-1) as medians with interquartile 
ranges (IQR). Samples in which bacterial DNA was not detected by qPCR 
were excluded from the statistical analysis. 
McNemar’s test was applied in the comparison of bacterial colonization 
rates between time points in the whole study population. Similarly, Wilcoxon 
signed-rank test was used in the assessment of differences in bacterial counts 
between the time points in the whole study population.  
Geeglm function from the R package geepack (Højsgaard et al., 2014) was 
used to fit a generalized estimating equations (GEE) model with a compound 
symmetry structure to determine the impact of the diet intervention on the 
bacterial detection rates. In this model, intervention type and time were added 
as independent variables, the primary variable measured at baseline was 
included as a covariate and individual was included as a random factor. A non-
parametric analysis of covariance (ANCOVA) was performed utilizing the 
sm.ancova function of the R package sm (Azzalini and Bowman, 2014) to 
assess statistically significant differences in the bacterial counts between the 








Cluster analysis of the DGGE patterns was performed by the UPGMA based 
on the Pearson correlation similarity coefficient as implemented in 
Bionumerics software version 6.6 (Applied Maths, Belgium). Analysis of 
variance (ANOVA) followed by Tukey HSD test was used to assess 
differences in means of richness and diversity calculated from the DGGE 
fingerprints between the different sample types. 
Unweighted and weighted UniFrac distances and sample metadata 
comprised the data matrices used as inputs for principal coordinate analysis 
(PCoA). Unweighted UniFrac distances compare microbial communities based 
on presence/absence of members (community membership: presence/absence 
matrix), and weighted UniFrac also incorporates relative abundance 
information (community structure:presence/absence/abundance matrix). PCoA 
plots were used to assess the variation in the composition of microbial 
communities between samples and to visualize potential clustering of samples 
by metadata. Samples were also hierarchically clustered based on their inter-
sample UniFrac distances using UPGMA. Biplots were generated as part of the 
beta diversity analyses, using genus level OTU tables showing principle 
coordinate sample clustering alongside weighted taxonomic group data. All 
beta-diversity measures were performed on OTU tables rarefied to 500 
sequences per sample for all samples to account for variations in sequencing 
depth. Pyrosequencing data on assigned sequences at family level shared 
between samples were used to generate a Venn diagram.  
After taxonomical assignment, relative frequencies of different taxonomic 
categories obtained were calculated using the Statistical Analysis of 
Metagenomic Profiles program (STAMP v.2.0.0). Statistical differences 
between experimental groups were estimated by ANOVA analysis with the 
Games-Howell post-hoc test and the multiple test correction of Benjamini-
Hochberg as implemented in STAMP. Multivariate statistical analysis and 
clustering were performed using METAGENassist software (Arndt et al., 
2012). Data-filtering was performed by the interquantile range method 
followed by quantile normalization within replicates after log transformation. 
Hierarchical clustering of OTUs were done using core microbiota defined as 
the OTUs that are present in at least 50% of the samples and Cluster analysis 
was performed using the Euclidean distance. Principal component analyses and 




A spearman’s correlation matrix was calculated for the HMO groups and 
different bacteria as well as individual HMO structures and the bacteria. 
Materials and Methods 
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Heatmaps of the correlation coefficients were constructed with the use of 
microbiome R package (Lahti and Salojärvi, 2012). 
4.2.12 Ethics 
The protocols of study II and III were approved by the College of Medicine 
research and ethics committee (University of Malawi) and the ethics committee 
of the Pirkanmaa Hospital District, Finland. The protocols of studies IV and V 
were approved by the Ethics committee of the Intermunicipal Hospital District 





5.1 Specificity of L. rhamnosus GG specific primers (I) 
The L. rhamnosus GG strain-specific PCR system targeting the putative 
transposase gene (Ahlroos and Tynkkynen, 2009) produced an amplicon of the 
expected size from eight of the tested 41 L. rhamnosus strains. Sequence 
analysis revealed that the eight strains shared completely identical sequences of 
the putative transposase gene, including L. rhamnosus GG. In contrast, the 
second L. rhamnosus GG specific PCR system targeting a phage-related gene 
produced an amplicon of an expected size from five of the 41 L. rhamnosus 
strains tested. The five strains were included in the eight strains that produced 
amplicons with the PCR system targeting the putative transposase gene. The 
strains LMG 18025, LMG 18030, and LMG 18038, originating from Egyptian 
fermented milk products, produced an amplicon with the first system but not 





Table 3. L. rhamnosus strains used in study I and their PCR reactions with two LGG strain-specific 
primer sets. 
      PCR reaction with 
Strain Source Country (year) Transposase* Phage† 
GG (ATCC 53103) Infant feces USA + + 
DSM 20021T     - - 
LMG 8153 Healthy adult urethra Canada - - 
LMG 10768 Human blood Sweden (1988) - - 
LMG 10770 Human bowel drain Sweden (1989) - - 
LMG 10772 Wine Sweden (1989) - - 
LMG 10773 Human sputum Sweden (1989) - - 
LMG 10775 Hip punction Sweden (1990) - - 
LMG 10776 Human pleura Sweden (1990) - - 
LMG 12166 Homemade cheese Yugoslavia (1968) - - 
LMG 18020 Mish cheese Egypt (1995) - - 
LMG 18025 Domiatti cheese Egypt (1992) + - 
LMG 18028 Laban Rayeb Egypt (1994) - - 
LMG 18030 Zabady (yogurt) Egypt (1992) + - 
LMG 18038 Domiatti cheese Egypt (1992) + - 
LMG 19716 Human blood Denmark - - 
LMG 19717 Human blood Denmark - - 
LMG 19720 Human blood Denmark - - 
LMG 23277 Human blood Belgium (1993) - - 
LMG 23278 Human pleural fluid Belgium (1994) - - 
LMG 23280 Human blood Belgium (1995) - - 
LMG 23282 Human blood Belgium (1997) - - 
LMG 23285 Human pus diverticulitis Belgium (1995) - - 
LMG 23288 Human throat Belgium - - 
LMG 23294 Human blood Belgium (1996) - - 
LMG 23296 Human bronchoalveolar 
lavage fluid 
Belgium (1999) - - 
LMG 23299 Human upper respiratory 
tract 
Belgium (1993) - - 
LMG 23302 Human bronchoalveolar 
lavage fluid 
Belgium (1997) - - 
LMG 23304 Human feces Belgium - - 
LMG 23320 Human blood Finland + + 
LMG 23325 Human blood Finland + + 
LMG 23522 Cheese Finland - - 
LMG 23524 Human feces Italy - - 
LMG 23525 Cheese Italy - - 
LMG 23527 Human feces Finland (1999) - - 
LMG 23534 Human feces Finland (1999) + + 
LMG 23550 Human blood UK (1990) - - 
LMG 23553 Human blood UK (1990) - - 
LMG 23667 Infant feces Sweden - - 
LMG 25859 Starter culture of probiotic 
yogurt drink 
Netherlands (2010) + + 
LMG 25881 Dairy product China (2010) - - 
*Putative transposase gene-targeting system 






The fingerprinting analysis by Rep-PCR, RAPD and ERIC PCR was carried 
out to distinguish the L. rhamnosus strains which produced amplicons with 
either one of the L. rhamnosus GG specific PCR systems. L. rhamnosus DSM 
20021T was included as a negative control. This analysis revealed that the 
strains originating from Egyptian fermented milk products (LMG 18025, LMG 
18030 and LMG 18038) and DSM 20021T were genotypically distinct from L. 
rhamnosus GG, while strains LMG 23320 and LMG 23325 originating from 
human blood in Finland, LMG 23534 originating from human feces in Finland, 
and LMG 25859, a dairy starter strain, produced very similar profiles to L. 
rhamnosus GG. Clustering analysis of the fingerprinting data indicated that the 
tested strains fell into two clusters (Figure 10). The first cluster contained the 
strains originating from the Egyptian fermented milk products, which were 
highly similar between each other, but showed less than 60% similarity with L. 
rhamnosus GG. The second cluster contained the strains L. rhamnosus GG, 
LMG 23520, LMG 23525, LMG 23534, and LMG 25859 and they shared over 
90% similarities. The L. rhamnosus type strain, DSM 20021T, was distinct 




Figure 10. Dendrogram based on cluster analysis of the composite data set of 
the ERIC PCR, RAPD and rep-PCR fingerprinting 
5.2 Lactobacillus microbiota of Finnish and Malawian 
infants (II) 
Clinical characteristics of the study II infants are presented in Table 4. In 
Malawi, all infants were breastfed and received local complementary foods 
including liquids such as tea, water and rice water, and solid foods such as thin 
maize porridge and bean and fish soups. In Finland, three of the 31 infants 
were exclusively breastfed, while 18 infants received breast milk and 




peach, banana and blueberry), chicken or fish meat, and cereals (e.g. oats and 
rice). Ten of the Finnish infants received infant formula instead of breast milk 
and complementary foods (Table 4). The mean age when infant formula was 
introduced to these infants was 2.2 (SD 2.2) months. 
Table 4. Clinical characteristics of the infants (Grześkowiak et al., 2012a) 
Clinical characteristics 
Malawian infants 
(n = 44) 
Finnish infants 
(n = 31) P-value 
Sex    
Male 20/44 (45.5%) 14/31 (45.2%) 1.000 
Female 24/44 (54.5%) 18/31 (54.8%) 1.000 
Age (months) 6 (5.6-6.0) 6.1 (5.9-6.4) 0.007 
Weight (kg) 6.6 (6.2-7.2) 8.1 (7.5-8.7) < 0.001 
Mode of delivery (% vaginal) Not available 24/31 (77.4%) n/a 
Breastfeeding 44/44 (100.0%) 21/31 (67.7%) < 0.001 
Breast milk + complementary 
food 
44/44 (100.0%) 18/31 (58.1%) 
< 0.001 
Breast milk + complementary 
food + formula 
Non-existent 3/31 (9.7%) 0.067 
Formula + complementary 
food 
Non-existent 10/31 (32.2%) 
< 0.001 
Breast milk + complementary 
food + animal milk* 
18/44 (40.9%) None <0.001 
*animal milk includes cow’s and goat’s milk 
The P-value indicates the differences between the two groups as analyzed by 
the Mann-Whitney U or Fisher’s exact tests. 
 
Lactobacilli were detected in all study II infants in Malawi and Finland, but 
the Malawian infants harboured higher counts of lactobacilli than the Finnish 
infants (7.45 log gene copies g-1 [95% CI 7.32–7.57] vs. 6.86 log gene copies g-1 
[95% CI 6.57–7.16]; P < 0.001, respectively) based on qPCR analysis. Based 
on PCR-DGGE analysis, bacterial richness determined based on the number of 
DNA fragments per sample was higher in Malawian compared with the Finnish 
infants (5 bands [IQR 3.25–6.00] vs. 4 bands [IQR 2.00–4.00]; P = 0.001, 
respectively). In addition, diversity (Shannon diversity index, H’) of the 
Lactobacillus-group microbiota was higher in Malawian infants than in the 





We also observed differences in the species composition of the 
Lactobacillus microbiota between the Malawian and Finnish infants. The 
Malawian infants had the species Leuconostoc citreum, Weissella confusa, L. 
ruminis, L. gasseri, L. acidophilus and L. mucosae more often than the Finnish 
infants 100.0% vs 74.2%, P < 0.001; 95.5% vs 41.9%, P < 0.001; 59.1% vs 
0.0%, P < 0.001; 38.6% vs 9.7%, P = 0.005; and 29.5% vs 0%, P < 0.001; 22.7% 
vs 3.2%, P < 0.017, respectively) (Table 5). However, L. casei group, L. 
delbrueckii and L. parabuchneri were detected more often in the Finnish 
infants compared with Malawians (0.0% vs. 58.1%, P < 0.001; 0.0% vs. 19.4%, 




































































































































































































































































































































































































































































A total of 18 Finnish samples (58.1% in total), which produced L. casei 
group bands in DGGE profiles, were further analyzed by species-specific PCR 
with L. rhamnosus-, L. paracasei-, and L. casei specific primer sets and an L. 
rhamnosus GG strain-specific primer set. All of the 18 samples presented L. 
rhamnosus, 8 of them presented L. paracasei, but none had L. casei. 
Furthermore, the strain L. rhamnosus GG was detected in 10 of the Finnish 
samples. Interestingly, L. rhamnosus group was more common in breastfed 
infants than in the formula fed infants in Finland (76.2% vs. 20.0%, p = 0.005). 
UPGMA analysis of the DGGE fingerprints based on the Pearson correlation 
coefficients revealed two main clusters (Figure 11). Cluster 1 composed of 
infants from both countries and was characterized by bright bands identified as 
Leuconostoc citreum and Weissella confusa. Moreover, Cluster 1 included a 
Malawian sub-cluster that was distinguished by a strong L. ruminis band. 
Cluster 2 composed of only Finnish infants, which produced a bright L. casei 
group band and a weak or no Leuconostoc or Weissella bands. Similar 
clustering was seen in principal components analysis (Figure 12), which was 






Figure 11. UPGMA dendrogram illustrating the correlation between the 
DGGE-fingerprints of Malawian and Finnish samples. The bands that had 
major influence in the clustering analysis are numbered and identified as 
follows: 1. Weissella confusa, 2. Leuconostoc citreum, 3. Lactobacillus ruminis 






Figure 12. Principal component analysis score plot based on the Lactobacillus 
DGGE-fingerprints of Malawian and Finnish infants’ faecal samples. Principal 
components 1 and 2 accounted for 17.9% and 11.1% of the variance, 
respectively. The cluster names correspond to the ones shown in Figure 11. 
5.3 Impact of lipid-based nutrient supplements on 
Malawian infants’ microbiota (III) 
Clinical characteristics of the study III infants are presented in Table 6. No 
clinically significant differences were detected between the intervention groups 
at baseline. Only two of the study infants had been exclusively breastfed, while 
the others had received complementary local foods (Table 6). Five infants in 
study III were hospitalized during the follow up due to pneumonia, anemia or 


















































































































































































































































































































































































































































































































































































































































































































































































































Bifidobacteria were detected in all study III infants and the highest 
colonization rates were noted for the species B. longum, B. bifidum, B. infantis 
and B. breve, which were all detected in at least 90% of the infants at baseline 
(Table 7). In general, bifidobacteria seemed to form a major part of the gut 
microbiota of the study III infants with bacterial counts reaching 1010 cells g-1 
of feces and higher for the species B. longum and B. infantis across all 
intervention groups at baseline samples from the 6 month old infants (Table 8). 
The dietary supplements did not have an impact on the colonization rates or 
bacterial counts when the analysis was controlled for baseline values (p > 0.05). 
However, changes in the microbiota composition were observed in the whole 
population over time. At twelve months, all study III infants still harboured 
bifidobacteria in their feces, but the colonization rates of B. longum, B. bifidum, 
B. infantis, B. breve and B. lactis were lower at twelve months compared to six 
months of age (100% vs. 91.7%, p = 0.001; 94.5% vs. 82.8%, p = 0.001; 94.5% 
vs. 84.1%, p = 0.012; 95.9% vs. 83.4%, p = 0.001; and 78.6% vs. 60.0%, p < 
0.001, respectively) (Table 7). In addition, S. aureus was detected at a lower 
abundance at twelve than at six months of age (31.0% vs. 13.8%, p < 0.001) 
(Table 7).  
We also found shifts in the total bacterial counts over time. The total 
bacterial count was slightly higher at twelve months of age (11.1 log gene 
copies g-1, IQR 10.2 – 11.9 vs. 11.4 log gene copies g-1, IQR 10.8 – 11.8, p = 
0.028). Also the Bifidobacterium genus counts were slightly higher (10.5 log 
gene copies g-1, IQR 9.8 – 11.0 vs. 10.7 log gene copies g-1, IQR 10.2 – 11.1, p 
= 0.027) even though the colonization rates of different Bifidobacterium 
species were generally lower after the intervention (Table 8). However, counts 
of B. infantis, B. lactis and B. longum decreased (10.5 log gene copies g-1, IQR 
9.1 – 11.5 vs. 9.4 log gene copies g-1, IQR 7.6 – 10.7, p < 0.001; 4.0 log gene 
copies g-1, IQR 3.3 – 4.7 vs. 3.3 log gene copies g-1, IQR 0.0 – 4.4, p < 0.001; 
and 10.1 log gene copies g-1, 9.5 – 10.7 vs. 9.8 log gene copies g-1, 8.9 – 10.3, p 
< 0.001, respectively) while B. catenulatum increased (0.0 log gene copies g-1, 
IQR 0.00 – 2.9 vs. 4.0 log gene copies g-1, IQR 0.0 - 7.9, p = 0.031) at twelve 
months compared to six months of age (Table 8). Moreover, S. aureus counts 
were lower (0.0 log gene copies g-1, IQR 0.0 – 3.1 vs. 0.0 log gene copies g-1, 































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































5.4 Microbial contact in utero and in early infancy (IV) 
Altogether 15 mother-infant pairs from whom maternal feces, placenta, 
amniotic fluid, colostrum, meconium and infant feces samples were available 
for analysis were included in study IV. All study neonates were born by 
elective cesarean section at full term with no symptoms or signs of intrauterine 
infection. One mother received antenatal antibiotic therapy with clindamycin 
for a bacterial infection of the skin whilst the remaining 14 mothers received no 
antibiotics prior to or during the cesarean section. None of the neonates were 
administered antibiotics during the test period. Clinical details of the study IV 
mother-infant pairs are presented in Table 9. 
 
















1 breach position clindamycin 39 1/7 male 3400 9 
2 hemorrhoids none 39 3/7 male 3750 9 
3 pelvic diameter none 39 1/7 female 3230 9 
4 breach position none 39 3/7 male 3470 9 
5 pelvic diameter none 38 6/7 female 3100 9 
6 previous section none 39 3/7 female 4325 7 
7 pelvic diameter none 39     female 3720 9 
8 fear of childbirth none 39 1/7 female 3595 9 
9 breach position none 39 1/7 female 3980 8 
10 breach position none 39     male 3490 10 
11 breach position none 39     female 3000 10 
12 previous section none 39     female 3250 10 
13 placenta praevia none 38 1/7 female 2770 9 
14 previous section none 38 6/7 male 3200 9 
15 fear of childbirth none 39 1/7 male 3670 9 
 
Based on 16S rRNA gene pyrosequencing and PCR-DGGE analysis, we 
found a unique microbial community in the placenta and amniotic fluid that 
was clearly distinct from the microbial community in the maternal feces 
(Figure 13, 14 and 15). We could not obtain PCR products from the negative 
controls for further analysis. The microbial populations in the amniotic fluid 
and placenta samples were highly consistent across individuals with low 










Figure 14. Principal Coordinate Analysis (PCoA) plot based on the unweighted 
UniFrac distance matrix. Individual samples of maternal feces (pink), placenta 
(yellow), amniotic fluid (red), colostrum (light blue), meconium (dark blue), 





Figure 15. UPGMA Cluster analysis using Pearson correlation coefficient 
performed on PCR-DGGE analysis fingerprints from mother feces (M), 
placenta (PL), amniotic fluid (AF), colostrum (C), meconium (Me) and infant 








Figure 16. Richness and diversity of the gut microbiota in mother feces (M), 
placenta (PL), amniotic fluid (AF), colostrum (C), meconium (Me) and infant 
feces (INF) samples. The letters above the box-plots indicate results of Tukey 
HSD test following a significant 1-way ANOVA. Mean values not sharing the 
same letters are significantly different from each other (p < 0.05) 
 
Proteobacteria was the predominant phylum in the amniotic fluid and 
placenta samples with a high abundance of species belonging to the 
Enterobacteriaceae family. At genus level, Enterobacter and 
Escherichia/Shigella were the most predominant Proteobacteria in these 
samples (Figure 13). These genera were also detected in colostrum, meconium 
and infant feces, but their levels were relatively low compared to other genera. 
Propionibacterium was the second most predominant genus detected in 
amniotic fluid and placenta, and was also detected in meconium. Streptococcus 
genus was present in the amniotic fluid, placenta and meconium samples, but in 
low abundance (< 1%). However, this genus was present in higher abundance 
in colostrum and infant feces (12% and 24%, respectively). Staphylococcus 
genus was also present in amniotic fluid (< 1%) and placenta (< 1%), but in 
lower abundance when compared to meconium samples (20%). Moreover, 
Lactobacillus genus was present in amniotic fluid, placenta, colostrum and 
meconium samples. Interestingly, we successfully retrieved staphylococci and 
propionibacteria by culturing from the placenta and amniotic fluid samples 
(Table 10).  
In colostrum samples, the microbiota composition was more varied with 
higher richness and diversity (Figure 16) compared to other sample types. 
Similar to amniotic fluid and placenta samples, Proteobacteria and 






Table 10. Identification of cultured microbial isolates from amniotic fluid and 






Amniotic fluid Propionibacterium (uncultured) S000565825 0.930 
Amniotic fluid Propionibacterium granulosum S001331259 0.987 
Amniotic fluid Propionibacterium acnes S001549679 0.983 
Amniotic fluid Propionibacterium (uncultured) S001028822 0.994 
Amniotic fluid Streptomyces puniceus S000581716 0.579 
Amniotic fluid Propionibacterium granulosum S001331269 0.985 
Amniotic fluid Propionibacterium acnes S001549679 0.964 
Amniotic fluid Staphylococcus (uncultured) S001245567 0.491 
Amniotic fluid Staphylococcus epidermis S00345154 1.000 
Amniotic fluid Propionibacterium acnes S001381916 0.974 
Amniotic fluid Lachnospiraceae (uncultured) S001245230 0.800 
Amniotic fluid Propionibacterium (uncultured) S001245230 0.952 
Amniotic fluid Propionibacterium (uncultured) S001245230 0.974 
Amniotic fluid Propionibacterium (uncultured) S000381988 0.969 
Amniotic fluid Staphylococcus lugdunensis S000381988 0.978 
Amniotic fluid Propionibacterium (uncultured) S001089380 0.986 
Placenta Propionibacterium acnes S001549675 0.955 
Placenta Propionibacterium acnes S001549679 0.971 
Placenta Propionibacterium (uncultured) S001247911 1.000 
Placenta Propionibacterium (uncultured) S001245230 9.966 
Placenta Staphylococcus pasteuri S000995943 1.000 
Placenta Staphylococcus warneri S001794135 0.991 
Placenta Propionibacterium (uncultured) S001248017 0.958 
Placenta Propionibacterium (uncultured) S001245230 0.978 
 
The meconium microbiota shared features with the placenta, amniotic fluid 
and colostrum microbiota (Figure 17). Forty-one of the 75 bacterial family 
phylotypes at the family level detected in meconium samples were also present 
in amniotic fluid and placenta samples. Additional 15 phylotypes at family 
level were shared between meconium and amniotic fluid samples, but not with 
placenta samples. In some mother-infant pairs, the meconium microbiota was 
similar to colostrum microbiota. Of the 75 bacterial family phylotypes detected 
in meconium, 54 were also observed in colostrum (Figure 17). Also, colostrum, 
amniotic fluid and placenta samples shared features in their microbial 
composition to some extent (Figure 17). The microbial composition in infant 
fecal samples collected later during the first week of life was clearly distinct 
from the meconium microbiota and resembled more that in colostrum (Figures 
15 and 17). 
Taken together, a core microbiome consisting of OTUs detected in 50% of 
each sample type was found to include Streptococcus, unclassified 
Enterobacteriaceae, Propionibacterium, Lactobacillus and unclassified 




Propionibacterium were present in all placenta, amniotic fluid and meconium 
samples. 
 
Figure 17. Venn diagrams of exclusive and shared bacterial phylotypes at 
family level in mother feces (M), placenta (PL), amniotic fluid (AF), colostrum 
(C), meconium (Me) and infant feces (INF) samples based on 16S rRNA gene 
pyrosequencing. 
 
5.5 Influence of HMOs on breast milk microbiota 
composition (V) 
In study V, eleven colostrum samples (from mothers engaged in study IV) 
were available for microbial and HMO analysis. Clinical characteristics of the 











Gender Birthweight  
(grams) 
Apgar score 
at 5 minutes 
1	 39	1/7	 female	 3230	 9	
2	 39	3/7	 male	 3470	 9	
3	 38	6/7	 female	 3100	 9	
4	 39	3/7	 female	 4325	 7	
5	 39	 female	 3720	 9	
6	 39	1/7	 female	 3595	 9	
7	 39	1/7	 female	 3980	 8	
8	 37  female	 3850	 9	
9	 39	 male	 3490	 10	
10	 37 4/7  male	 2740	 9	
11	 39	 female	 3000	 10	
  
The mean concentrations of the HMOs detected in the colostrum samples 
are presented in Table 12. The most abundant HMOs in the samples were 2’-
fucosyllactose (2’-FL), lacto-N-fucopentaose (LNFP I), difucosyl-lacto-N-
tetraose (DF-LNT) and lacto-N-tetraose (LNT) with mean concentrations 
(μg/ml) of 2 733 (SD 512), 1832 (SD 639) and 958 (SD 218), respectively 
(Table 12). The oligosaccharide profile of the human milk is dependant on the 
expression of glycosyltransferases and the secretor type which is defined by the 
ability to encode alpha1,2-fucosyltransferase FUT2 (Kobata, 2010). In study V, 
all mothers were identified as secretors as indicated by the presence of 2’-FL or 





Table 12. Mean concentrations (μg/ml) with standard deviations of human milk 
oligosaccharides in colostrum samples (n = 11), analyzed by high-pressure 
liquid chromatography 
HMO Mean (SD) 
2'FL 2733 (512) 
3FL 50 (34) 
LNnT 409 (82) 
3'SL 413 (90) 
LNT 958 (219) 
LNFP I 1832 (639) 
LNFP II 466 (146) 
LNFP III 65 (21) 
LSTb 61 (19) 
LSTc 475 (248) 
DF-LNT 1140 (512) 
DS-LNT 285 (88) 
FLNH 93 (41) 
DFLNH 113 (41) 
FDSLNH 86 (40) 
DSLNH 96 (63) 
HMO, human milk oligosaccharide; SD, standard deviation 
 
Bacterial counts (log gene copies g-1) determined by qPCR are presented in 
Table 13. Bifidobacterium spp., Streptococcus spp., Bacteroides-Prevotella 
group and Lactobacillus group were detected in all of the colostrum samples 
(Table 13). Bifidobacterium spp. was the most abundant bacterial group 
followed by the Lactobacillus group (4.6, IQR 4.5 – 4.8; and 3.4, IQR 4.5 – 4.8, 
respectively). B. longum group was the most abundant bifidobacterial group 
followed by B. bifidum (Table 13). In contrast, B. breve was less common and 






Table 13. Median bacterial counts with interquartile range (IQR) (log gene 
copies g-1) and detection rates in colostrum samples (n=11), analyzed by qPCR 
Bacterium Median (IQR) 
Detection 
rate (%) 
Total bacteria 5.1 (5.0 – 5.8) 100.0 
Bifidobacterium spp. 4.6 (4.5 – 4.8) 100.0 
Bifidobacterium longum 3.9 (3.9 – 4.0) 100.0 
Bifidobacterium breve 0.0 (0.0 – 3.9) 45.5 
Bifidobacterium bifidum 2.7 (2.6 – 2.8) 100.0 
Staphylococcus spp. 4.5 (3.7 – 4.8) 81.8 
Staphylococcus aureus NUC 0.0 (0.0 – 2.0) 45.5 
Streptococcus group 2.0 (1.8 – 3.0) 100.0 
Lactobacillus group 3.4 (3.2 – 3.6) 100.0 
Enterococcus spp. 1.7 (1.3 – 1.8) 81.8 
Akkermansia muciniphila 0.9 (0.0 – 1.5) 63.6 
Bacteroides-Prevotella group 2.8 (2.7 – 3.2) 100.0 
Clostridium cluster XIVa - XIVb 4.6 (4.0 – 4.7) 81.8 
Clostridium cluster IV 2.8 (2.5 – 3.2) 81.8 
 
We discovered associations between different groups of HMOs (Figure 18a) 
and microbiota as well as individual HMO structures and microbes (Figure 
18b). The total HMO concentration correlated positively with Bifidobacterium 
spp. and B. breve (ρ = 0.63, p = 0.036 and ρ = 0.66, p = 0.027, respectively). 
Moreover, fucosylated HMOs correlated positively with Bifidobacterium spp., 
and Akkermansia muciniphila (ρ = 0.67, p = 0.024 and ρ = 0.70, p = 0.017, 
respectively) while the sialylated HMOs correlated with B. breve (ρ = 0.84 , p 
= 0.001). There was also a positive correlation between HMOs that were both 
fucosylated and sialylated and S. aureus (ρ = 0.75, p = 0.007) and HMOs that 
were neither fucosylated nor sialylated and B. longum group (B. longum subsp. 
infantis and B. longum subsp. longum) (ρ = 0.65, p = 0.030). Between 
individual HMOs and the microbiota, the strongest correlations were observed 
for LNT and B. longum group, LNFP III and B. breve, fucosyldisialyllacto-N-
hexaose (FDSLNH) and S. aureus, LNFP I and Akkermansia muciniphila, and 
LST c and B. breve (ρ = 0.82, p = 0.002; ρ = 0.79, p = 0.004; ρ = 0.75, p = 






Figure 18. Heat map of spearman rank correlations between human milk 
oligosaccharide groups and bacterial counts (a) and between individual human 
milk oligosaccharides and bacterial counts (b). Negative correlations are 






6.1 Evaluation of L. rhamnosus GG specific primers (I and 
II) 
PCR-based strain-specific identification using strain-specific primers is a 
valuable tool for identifying probiotics in commercial products as well as 
human specimens in intervention studies. The specificity of the primers used 
must be ensured to avoid false positive results. In study I we evaluated the 
specificity two previously published L. rhamnosus GG specific primer sets.  
The specific primer set targeting a transposase gene gave false positive 
results from three strains (LMG 18025, LMG 18030 and LMG 18038) which 
were clearly distinguishable from L. rhamnosus GG based on the results of 
fingerprinting analysis. On the other hand, the L. rhamnosus GG detection 
system targeting the phage-related gene described by Brandt & Alatossava 
(Brandt and Alatossava, 2003) detected L. rhamnosus GG and L. rhamnosus 
GG-like strains, suggesting that this system is a more reliable tool for the 
detection of L. rhamnosus GG. However, this system still produced amplicons 
from L. rhamnosus strains that were closely related to or nearly 
indistinguishable from L. rhamnosus GG using these primers. Interestingly, all 
of these isolates originated from human clinical samples from Finland. Finland 
has a long history of using L. rhamnosus GG in several food matrices and thus 
it would be tempting to speculate that L. rhamnosus GG might colonize and 
produce derivative strains in the human gut. Moreover, one of the positive 
strains (LMG 25859) is used as a starter strain for the probiotic yogurt drink 
Yoba. The strain was reported to originate from infant feces, suggesting that 
the strain is also a L. rhamnosus GG derivative. This was confirmed by a recent 
comparative genomics study, which suggested that this particular strain is a L. 
rhamnosus GG derivative which is missing the genomic islands that contain 
genes encoding pili subunits (Sybesma et al., 2013). 
In the present series (II), we detected L. rhamnosus GG in half of the L. 
rhamnosus positive fecal samples of Finnish infants, although neither the 
infants nor the mothers received any probiotic products, which further 
strengthens the hypothesis that L. rhamnosus GG may colonize the human gut 
and produce derivative strains. Similar findings have been reported earlier from 
Finland, where almost half of the fecal samples in a placebo group contained L. 
rhamnosus GG like strains (Gueimonde et al., 2006a). Nevertheless, it remains 




6.2 Impact of geographical location and diet on gut 
microbiota development during infancy (II and III) 
Diet, hygiene and geographical location have been reported to have an impact 
on the gut microbiota development in infancy. In the present series (II), we 
compared the gut microbiota composition between Malawian and Finnish 
infants, representing low-income and high-income countries respectively. 
These two countries offer completely different environments and dietary 
conditions. These are also reflected in the different prevalence of microbiota 
associated diseases including allergies, obesity and gastrointestinal disorders in 
Finland, and bacterial (or viral) diarrhea and malnutrition in Malawi. Moreover, 
we also studied whether lipid-based nutrient supplements affect the gut 
microbiota composition in Malawian infants over time (III). 
Earlier studies have indicated that Malawian infants have greater proportions 
of bifidobacteria, Bacteroides-Prevotella, and Clostridium histolyticum 
compared to Finnish infants, while the species Bifidobacterium adolescentis, 
Clostridium perfringens, and Staphylococcus aureus were only present in 
Finnish infants (Grześkowiak et al., 2012a). In the present series (II), we 
expanded the microbiota studies to species composition of lactobacilli which 
have been also identified among the first microbes to colonize the human 
gastrointestinal tract, possibly already in utero (Rautava et al., 2012b; Satokari 
et al., 2009). Lactobacilli also form the majority of the microbiota of the birth 
canal (Hummelen et al., 2010) and breast milk (Cabrera-Rubio et al., 2012). 
Lactobacilli are believed to be part of a healthy gut microbiota and thus 
members of this group are commonly used as probiotics as well. 
In study II, we observed that at 6 months of age, Malawian infants had a 
more abundant, richer and more diverse Lactobacillus microbiota compared to 
Finnish infants of the same age. This information may be useful in 
understanding why some gut-related diseases are more common in high-
income or low-income countries. Typically, higher levels of lactobacilli have 
been reported in the feces of infants from areas where allergic and immune-
mediated diseases are less common. For instance, higher levels of lactobacilli 
have been detected in Estonian versus Swedish infants (Sepp et al., 1997) and 
also in rural Thai infants versus Singaporean infants (Mah et al., 2008). 
However, it has been demonstrated that early colonization with specific 
lactobacilli is associated with the risk of developing allergy (Johansson et al., 
2011) and atopic dermatitis (Penders et al., 2010). The mechanisms behind the 
protective effect of early colonization by lactobacilli against these diseases are 
not well understood. 
Leuconostoc citreum and Weissella confusa were the most common 




in the Malawians. These species most likely originate from breast milk, since 
Leuconostoc spp. and Weissella spp. have been reported to be among the 
predominant bacteria in breast milk (Cabrera-Rubio et al., 2012). Surprisingly, 
these species have not, to our knowledge, been reported in infant fecal samples 
before. One possible reason for the non-detection of these two species in the 
former studies could be the fact that these organisms are sensitive to acids. The 
Lactobacillus microbiota was originally studied by culture-dependent methods 
utilizing acidified media, but the acidified media are not suitable for these acid-
sensitive organisms (Dal Bello et al., 2003). W. confusa has been shown to be 
less widely distributed in the feces of irritable bowel syndrome patients 
compared to healthy controls (Ponnusamy et al., 2011), but otherwise the role 
of Weissella and Leuconostoc in health and disease is not well known. Both of 
them have been considered as opportunistic pathogens associated with neonatal 
bacteremia (Svec et al., 2007), but our results suggest that these species are 
common inhabitants in the infant gut regardless of geographic location. 
A species identified as L. ruminis was only detected in Malawian infants (II). 
This bacterium has been described as one of the predominant Lactobacillus 
species in adults (Reuter, 2001), but only a few studies reported it as a part of 
the microbiota in infants. Another study has reported L. ruminis in Malawian 
infants as well (Yatsunenko et al., 2012), suggesting that this species could be a 
characteristic of infants from this area. This could mean that the Malawians 
develop a more adult-like Lactobacillus microbiota earlier than the Finnish 
infants. However, it is also possible that this species is of animal origin in the 
Malawian infants. The Malawians live in close contact with animals and L. 
ruminis has been identified as an indigenous species in several animals 
including pigs (Yin and Zheng, 2005), cows (Krause et al., 2003) and chickens 
(Kovalenko et al., 1989). 
L. casei group, mainly the species L. rhamnosus, was a characteristic of 
Finnish infants and encountered more often in the breastfed compared to 
formula-fed infants (II). Similarly, L. rhamnosus has been reported as a 
predominant Lactobacillus species in Sweden (Ahrne et al., 2005) and Greece 
(Mitsou et al., 2008). Interestingly, infants colonized by L. casei group were 
less often colonized by Leuconostoc spp. and Weissella spp. in our study (II). It 
is possible that these species share adhesion sites and may also compete for the 
same nutrients. Nevertheless, species of the L. casei group have been linked to 
a decreased risk of developing allergies (Johansson et al., 2011) and atopic 
dermatitis (Penders et al., 2010) and therefore this group of species could be 
considered as a healthy parameter in infants from Western countries. 
In study II, the DNA extraction process did not include mechanical 
disruption of the cells by repeated bead-beating that was used in the other 




some bacterial species (Nylund et al., 2010; Walker et al., 2015), but all 
samples were treated similarly and thus it should not affect the comparison 
between Finland and Malawi. However, it must be noted that the varying 
storage temperatures for the Malawian samples may have had an impact on the 
sample quality. 
We believe that the environment, including diet and hygiene, may be among 
the factors associated with the differences in bacterial profiles. In Malawi, local 
foods naturally rich in complex carbohydrates are introduced soon after birth 
whereas in Finland infant formula and complementary foods are introduced 
when breast-feeding is not sufficient. Plant polysaccharides have been reported 
as an important gut microbiota modulating factor in another African country, 
Burkina Faso (De Filippo et al., 2010). In addition, hygiene and the presence of 
animals in the living areas of the infants might also explain the observed 
differences in the microbiota between Malawi and Finland (II). In Malawi, 
hygiene standards are generally lower compared to Finland, and people live in 
close contact with animals. However, even indirect contact with animals might 
be enough for gut microbiota modulation. It has been reported that even the 
dust from a house which has pets, can increase the number of lactobacilli and 
protect against airway allergens in mice (Fujimura et al., 2013). 
Different strains of lactobacilli are often used as probiotics in clinical 
intervention studies, including cases of atopic eczema and the results have been 
promising for some probiotic strains (Elazab et al., 2013; Isolauri et al., 2000; 
Kalliomaki et al., 2003). Also, studies on probiotic use in one Norwegian birth 
cohort suggest that consumption of specific Lactobacillus probiotics during the 
perinatal period may promote a reduction in the risk of atopic eczema in infants 
(Bertelsen et al., 2014). As indicated in this study (II), Lactobacillus 
microbiota composition differs between countries during infancy and thus we 
could ask the question: could such differences have an impact on the efficacy 
of a probiotic? L. casei group species have been widely used for the same 
purposes in several countries around the globe, regardless of whether the 
species are indigenous to the population or not. Actually, L. rhamnosus Yoba, a 
derivative strain of LGG, is used as a “generic probiotic” in Southern Africa 
(Kort and Sybesma, 2012; Mpofu et al., 2014). The concept of generic 
probiotics refers to probiotic bacteria introduced under a novel brand name 
after intellectual property rights have expired, or when there is no patent 
coverage, or the use is restricted to certain countries, methods of use or clinical 
applications (Kort and Sybesma, 2012). The goal of this is to create access to 
probiotics for people in the developing world. 
As mentioned earlier, we also studied the impact of lipid-based nutrient 
supplements with different sources of protein on the gut microbiota 




been used in several clinical trials to improve growth in children from 
developing countries (Ashorn et al., 2015a, 2015b; Ciliberto et al., 2005; 
Maleta et al., 2015; Phuka et al., 2008; Sandige et al., 2004), but their impact 
on the gut microbiota has been unknown. Gut microbiota is closely linked to 
malnutrition (Gordon et al., 2012; Smith et al., 2013) and recent reports 
suggest that an immature microbiota in early infancy may reduce or even 
prevent successful nutritional interventions that aim to promote growth 
(Subramanian et al., 2014). 
Similar findings on Malawian infants from the same study volunteers as in 
our study (III) suggest that these supplements do not have an impact on the gut 
microbiota composition (Cheung et al., 2016). These findings were based on 
next-generation sequencing, and to complement them, we performed a targeted 
qPCR approach to monitor possible changes at species level that might have 
been lost in the high-throughput analysis. We targeted bifidobacteria due to 
their health-promoting properties and possible role in malnutrition (Collado et 
al., 2010; Dinh et al., 2016; Kalliomaki et al., 2001; Rautava et al., 2012b; 
Subramanian et al., 2014). For instance, a decline in the number of 
bifidobacteria, especially B. longum, has been noted to be associated with 
malnutrition in infants and young children from Bangladesh and South India 
(Dinh et al., 2016; Million et al.; Subramanian et al., 2014). 
We included S. aureus as an additional target due to its clinical relevancy 
and possible impact on body weight (Kalliomaki et al., 2008; Song et al., 2014; 
von Mutius and Radon, 2008). Previous studies have also demonstrated that S. 
aureus is a characteristic of infants from developed world while remaining rare 
in infants from developing countries such as Malawi (Grześkowiak et al., 
2012a, 2012b). Interestingly, it has been shown that S. aureus may trigger the 
occurrence of sCD14 in plasma and therefore it has been hypothesized that 
perinatal colonization by S. aureus may lower the risk of allergic 
manifestations (Lundell et al., 2007; Salminen et al., 2016). 
In this series (III), the lipid-based nutrient supplements or the corn-soy 
blend did not have an impact on the measured bacterial populations. However, 
some dietary components including micronutrients, such as iron, have been 
shown to have a negative impact on the developing gut microbiota by 
decreasing the numbers of bifidobacteria and promoting a more pathogenic 
microbial profile with increased levels of enterobacteria in children from both 
low- and high-income countries (Zimmermann et al., 2010; Krebs et al., 2013). 
Nevertheless, when looking at the study population (III) as a whole, we saw 
shifts in bacterial colonization rates and counts in the Malawian infants over 
time. In general, the Bifidobacterium microbiota seemed to change towards a 
more of an adult type profile with lower prevalence of B. infantis, B. lactis, B. 




bifidobacteria in infants, and higher levels of B. catenulatum, a bifidobacterium 
more often encountered in adults (Junick and Blaut, 2012; Matsuki et al., 1999, 
2004). 
Deviations in the microbiota composition are critical to early immune 
programming and influence the health of the infant and risk of subsequent 
disorders. Therefore, dietary interventions aiming to promote growth should 
also promote normal gut microbiota development to improve the impact of 
nutrition supplementation in young infants at risk of malnutrition. 
6.3 Microbial colonization in early life (IV and V) 
In addition to a variety of environmental factors, a number of host factors may 
influence the gut microbiota development. In the present study (IV), we 
assessed the impact of maternal microbiota on infant gut microbiota 
development from a nontraditional point of view by studying the possible 
microbial contact in utero and during the first days of life by comparing 
microbiota in amniotic fluid, placenta, meconium, colostrum, infant feces and 
maternal feces. In addition, we assessed how colostrum human milk 
oligosaccharide (HMO) content interacts with the colostrum microbiota itself 
(V).  
Contrary to earlier beliefs, recent reports suggest that fetus might be exposed 
to microbes and/or microbial DNA already in the placenta without adverse 
pregnancy outcomes  (Aagaard et al., 2014; Rautava et al., 2012b). In our study 
(IV), we also found a unique microbial community in the placenta and 
amniotic fluid, which may provide the initial inoculum for gut colonization. 
Our findings were consistent with previous reports on placenta microbiota 
indicating a predominance of Proteobacteria, especially species belonging to 
the Enterobacteriaceae family (Aagaard et al., 2014; Antony et al., 2015; 
Zheng et al., 2015). These findings, including ours (IV), suggest that the 
microbiota in the placenta is consistent between healthy individuals, which 
could mean that there are selective mechanisms to introduce specific maternal 
microbes or microbial parts to the fetus. 
The origin of the intrauterine microbiota remains to be fully uncovered. 
Similarities between human oral and placental microbial communities have 
been reported (Aagaard et al., 2014). Nevertheless, the study relied on oral 
microbiota data from a previous report based on non-pregnant individuals and 
the mechanism of possible bacterial transportation between these maternal 
compartments remains unknown. However, it has been demonstrated in 
laboratory animals that intestinal bacterial translocation is increased during 
pregnancy (Koren et al., 2012; Perez et al., 2007). Moreover, specific labeled 




well as the meconium of the neonate after sterile cesarean section (Jimenez et 
al., 2008). A more recent study by Agüero and coworkers (2016) utilizing 
germ-free experimental animals demonstrated that nonviable bacterial 
fragments are transferred to placenta where they stimulate the immune system 
development of the fetus. However, the authors were not able to culture the 
described microbes from the placenta or the neonate. 
In the present series (IV), we were able to culture bacteria from some of the 
placenta and amniotic fluid samples. However, most of the other studies 
investigating placenta or amniotic fluid microbiota in humans have only used 
culture-independent methods. Based on them, it cannot be concluded whether 
there are viable, intact bacteria in placenta or amniotic fluid. The bacterial 
DNA that is detected using PCR-based techniques could be present in the 
intracellular space or, for instance, within immune cells. It is also important to 
keep in mind that sequencing of low biomass samples is prone to PCR bias and 
thus the results may present a distorted image of the real bacterial population in 
such samples. Whether or not viable microbes exist in the amniotic fluid or 
placenta, it has been noted that already the bacterial DNA or other lifeless 
microbial parts may influence the immune system maturation of the fetus in 
utero (Agüero et al., 2016; Rautava et al., 2012a). 
In our study (IV), placenta samples were collected during elective cesarean 
section to avoid contamination by microbes from the birth canal or maternal 
feces. Moreover, mothers who presented with rupture of membranes, labour or 
signs of infection were excluded from the study. Contamination of the DNA 
extraction and PCR reagents has been recognized as a major concern when 
studying samples with low bacterial population (Laurence et al., 2014; Salter et 
al., 2014; Spangler et al., 2009). Therefore, we used controls containing no 
template within the DNA extraction and PCR to rule out the possibility of 
contamination, and we could not obtain amplicons of 16S rRNA gene 
sequences for further analysis.  
In contrast to our findings, a recently published study demonstrated that 
placental samples could not be reliably distinguished from background 
contamination controls using qPCR and 16S rRNA gene sequencing combined 
with two different methods for DNA extraction (Lauder et al., 2016). 
Nevertheless, the authors found some extremely low abundant OTUs from the 
maternal side (basal plate) of the placental samples that could represent 
sporadic, and potentially rather rare placental microbiota (Lauder et al., 2016). 
If true, this would be in accordance with earlier reports on intact intracellular 
microbes in the basal plate (Stout et al., 2013). This study demonstrates that 
possibly new optimized DNA extraction methods and pipelines with lower 
detection limits are needed for reliable analysis of low biomass samples. Such 




numbers of bacterial DNA could be reproducibly detected with no 
contaminations in brain, muscle, adipose tissue, liver and heart (Lluch et al., 
2015). 
Several reports suggest that microbes are also present in meconium 
(Dominguez-Bello et al., 2010; Gosalbes et al., 2013; Mshvildadze et al., 
2010), but their source has been unknown. It has been speculated that the 
microbes or microbial DNA may be derived from swallowing amniotic fluid 
(Ardissone et al., 2014). In the present series (IV), the meconium microbiota 
shared some similarities with amniotic fluid and placenta, but also that in the 
colostrum. The meconium samples (IV) were collected during the first two 
days of life, during which all infants had been breastfed from the first hours of 
life. Therefore it is possible that microbes of colostrum may have already had 
an impact on the meconium microbiota in some individuals. It is also possible 
that these microbes originated from other postnatal environmental sources 
because the meconium samples were collected non-invasively from diapers. 
Though, it is also possible that meconium and colostrum microbiota share a 
common maternal source if microbes or microbial parts are actively transferred 
from the maternal gut to mammary gland and placenta, as suggested by some 
research groups (Agüero et al., 2016; Jimenez et al., 2008; Perez et al., 2007).  
Although the transfer of microbes or microbial compounds to placenta has 
been demonstrated in experimental animals (Agüero et al., 2016; Jimenez et al., 
2005, 2008), production of germ-free animals is still possible by hysterectomy 
(Arvidsson et al., 2011) and embryo transfer (Inzunza et al., 2005). This 
suggests that maybe permanent colonization does not happen in utero or it may 
only happen during the final stages of the pregnancy. In the future, this 
phenomenom should be studied more carefully when deriving germ-free 
animals to demonstrate whether there are microbes or microbial parts in the 
placenta or the fetus. To our knowledge, there have been no studies on the 
bacterial load of germ-free derived animals at their fetal stage utilizing modern 
technologies. It has been suggested that microbes or microbial parts may also 
be washed out or sterilized during the derivation procedure of germ-free 
animals since the concentration of microbes in placenta and amniotic fluid 
appears to be very low (Reid et al., 2015). It also remains unknown how active 
the microbes in these sites are in the first place. 
The role of placenta or meconium microbiota in health and disease is not 
well understood. However, some recent reports suggest that both the placenta 
and meconium microbiota may reflect the health status of the mother. Altered 
placenta and meconium microbiota has been associated with preterm birth 
(Ardissone et al., 2014; Prince et al., 2016). The placenta microbiota was 
reported to be altered with and without chrioamnionitis compared to healthy 




associated with low birth weight in full term neonates (Amarasekara et al., 
2015). In addition to reflecting the health status of the mother (Hu et al., 2013) 
to the meconium microbiota has also been associated with development of 
diseases in the offspring (Gosalbes et al., 2013). 
The microbial colonization process continues after birth via breastfeeding. 
After birth, breast milk serves both as the most important source of microbes 
and of other microbiota modulating factors, such as HMOs (Jost et al., 2015). 
In the studies IV and V presented here, all mothers delivered by cesarean 
section, which may affect the colostrum microbiota composition possibly as a 
result of hormonal changes produced during labor (Cabrera-Rubio et al., 2012, 
2016). The infant fecal microbiota at 3-4 days was notably similar to the 
colostrum microbiota. However, based on the current sample material (IV), we 
can only hypothesize that the breast milk microbes contribute to the gut 
colonization during early infancy. To make robust conclusions on the role of 
breast milk microbes in gut microbiota development, formula fed infants and 
breastfed infants should be compared in future studies.  
The impact of HMOs on infant microbiota has been reported (De Leoz et al., 
2015; Wang et al., 2015), but it has been unknown whether the HMOs 
influence the human milk microbiota composition itself. Our results suggest 
that the HMO content of human milk and the human milk microbiota are 
interrelated (V).  
Specific species of bifidobacteria are known for their ability to consume 
HMOs (Bode, 2012), which may explain some of our findings in study V. For 
instance, we saw an association between B. longum group bacteria and LNT, 
one of the core HMOs of both secretors and non-secretors, and subspecies of 
this bacterial group are known for their ability to metabolize this specific HMO 
by utilizing lacto-N-biosidase (LoCascio et al., 2010; Sakurama et al., 2013). 
In addition to bifidobacteria, HMO content was associated with counts of S. 
aureus and Akkermansia muciniphila. HMOs have been reported to promote 
the growth of S. aureus (Hunt et al., 2012), but for Akkermansia muciniphila 
HMO metabolism has not been documented. However, the genome of 
Akkermansia includes a variety of genes, such as sialidases and fucosidases, 
which suggest that this bacterium could also metabolize HMOs (Derrien et al., 
2004). These results suggest that the impact of HMOs is not limited to the 
infant, but also to the microbial composition of human milk. 
In conclusion, our results suggest that the fetus may be exposed to microbes 
already in utero, and the gut colonization continues in a step-wise manner 
following birth via microbes in breast milk, which is directed by host factors 
such as HMO composition of the milk. The final two parts of the study series 
(IV and V) are based on a relatively small cohort and thus future research 




the placenta and the amniotic fluid samples and to elucidate their potential role 
for infant health. Bacterial transfer from mother to infant may provide a new 
target for clinical interventions aiming at improving the pregnant mother’s 
nutrition and microbiota for further impact on reducing the inflammatory non-
communicable disease risk by modulating the early host-microbe interactions 
and later programming of infant health. This will require new technologies and 
methods to assess the microbiota and its deviations. This would form the basis 





Exposure to microbes and microbial structures in early life is crucial for the 
normal development of the gut microbiota and immune system maturation. 
Human gut microbiota development is a step-wise process, which possibly 
starts already during the fetal stages of life, based on our findings. Following 
birth, the microbiota development continues via the introduction of microbes 
and microbiota modulating factors in human milk, whose composition varies 
between individuals. Moreover, the environment plays a role in introducing 
microbes to the infant and the microbiota development is affected by 
environmental factors such as hygiene, sanitation and geographical location as 
demonstrated by the results in the present series. 
It may be possible to modulate the gut microbiota composition at different 
stages of development to reduce the risk of non-communicable diseases, 
including allergic, autoimmune and anti-inflammatory diseases, such as obesity. 
In addition, gut microbiota modulation during infancy may provide a new 
complementary approach to promote growth of infants at risk of malnutrition. 
Nevertheless, further knowledge on the mechanisms of host-microbe 
interactions as well as functional capability of the human microbiota is needed, 
since the microbiota composition itself does not necessarily reflect the function 
profile that it has. This can be achieved by utilizing metagenomic, 
metatranscriptomic and metaproteomic approaches among others, but the cost 
of these methods remains high today and the data analysis methods are still 
under development, In addition, the role of archaeae, viruses and parasites in 
human health remains to be elucidated.  
It is also plausible that microbiota research expands from the gastrointestinal 
tract to other niches as well. Microbes or microbial parts have been discovered 
in various niches previously thought to be sterile, at least in healthy individuals, 
including blood and several tissues, but their role in health and disease remains 
to be elucidated. For this purpose, novel optimized methods for analysing low 
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